                               SEQUENCE LISTING

<110> MEMORIAL SLOAN KETTERING CANCER CENTER
      UNIVERSITY OF RHODE ISLAND BOARD OF TRUSTEES
      PHLIP, INC.
 
<120> RADIOLABELED LIGANDS FOR TARGETED PET/SPECT IMAGING AND METHODS 
      OF THEIR USE

<130> 115872-2306

<140> PCT/US2021/051322
<141> 2021-09-21

<150> 63/242,315
<151> 2021-09-09

<150> 63/081,632
<151> 2020-09-22

<160> 244   

<170> PatentIn version 3.5

<210> 1
<211> 27
<212> PRT
<213> Artificial Sequence

<220>
<223> Description of Artificial Sequence: Synthetic
      peptide


<220>
<221> MOD_RES
<222> (1)..(27)
<223> D-amino acid

<400> 1
Ala Cys Asp Asp Gln Asn Pro Trp Arg Ala Tyr Leu Asp Leu Leu Phe 
1               5                   10                  15      


Pro Thr Asp Thr Leu Leu Leu Asp Leu Leu Trp 
            20                  25          


<210> 2
<211> 27
<212> PRT
<213> Artificial Sequence

<220>
<223> Description of Artificial Sequence: Synthetic
      peptide


<220>
<221> MOD_RES
<222> (1)..(27)
<223> D-amino acid

<400> 2
Ala Cys Asp Gln Asp Asn Pro Trp Arg Ala Tyr Leu Asp Leu Leu Phe 
1               5                   10                  15      


Pro Thr Asp Thr Leu Leu Leu Asp Leu Leu Trp 
            20                  25          


<210> 3
<211> 27
<212> PRT
<213> Artificial Sequence

<220>
<223> Description of Artificial Sequence: Synthetic
      peptide


<220>
<221> MOD_RES
<222> (1)..(27)
<223> D-amino acid

<400> 3
Ala Lys Asp Asp Gln Asn Pro Trp Arg Ala Tyr Leu Asp Leu Leu Phe 
1               5                   10                  15      


Pro Thr Asp Thr Leu Leu Leu Asp Leu Leu Trp 
            20                  25          


<210> 4
<211> 27
<212> PRT
<213> Artificial Sequence

<220>
<223> Description of Artificial Sequence: Synthetic
      peptide


<220>
<221> MOD_RES
<222> (1)..(27)
<223> D-amino acid

<400> 4
Ala Lys Asp Gln Asn Asn Pro Trp Arg Ala Tyr Leu Asp Leu Leu Phe 
1               5                   10                  15      


Pro Thr Asp Thr Leu Leu Leu Asp Leu Leu Trp 
            20                  25          


<210> 5
<211> 28
<212> PRT
<213> Artificial Sequence

<220>
<223> Description of Artificial Sequence: Synthetic
      peptide


<220>
<221> MOD_RES
<222> (1)..(27)
<223> D-amino acid

<400> 5
Ala Asp Asp Gln Asn Pro Trp Arg Ala Tyr Leu Asp Leu Leu Phe Pro 
1               5                   10                  15      


Thr Asp Thr Leu Leu Leu Asp Leu Leu Trp Cys Gly 
            20                  25              


<210> 6
<211> 28
<212> PRT
<213> Artificial Sequence

<220>
<223> Description of Artificial Sequence: Synthetic
      peptide


<220>
<221> MOD_RES
<222> (1)..(27)
<223> D-amino acid

<400> 6
Ala Asp Gln Asp Asn Pro Trp Arg Ala Tyr Leu Asp Leu Leu Phe Pro 
1               5                   10                  15      


Thr Asp Thr Leu Leu Leu Asp Leu Leu Trp Cys Gly 
            20                  25              


<210> 7
<211> 28
<212> PRT
<213> Artificial Sequence

<220>
<223> Description of Artificial Sequence: Synthetic
      peptide


<220>
<221> MOD_RES
<222> (1)..(27)
<223> D-amino acid

<400> 7
Ala Asp Asp Gln Asn Pro Trp Arg Ala Tyr Leu Asp Leu Leu Phe Pro 
1               5                   10                  15      


Thr Asp Thr Leu Leu Leu Asp Leu Leu Trp Lys Gly 
            20                  25              


<210> 8
<211> 29
<212> PRT
<213> Artificial Sequence

<220>
<223> Description of Artificial Sequence: Synthetic
      peptide


<220>
<221> MOD_RES
<222> (1)..(28)
<223> D-amino acid

<400> 8
Ala Lys Asp Gln Asn Asn Pro Trp Arg Ala Tyr Leu Asp Leu Leu Phe 
1               5                   10                  15      


Pro Thr Asp Thr Leu Leu Leu Asp Leu Leu Trp Lys Gly 
            20                  25                  


<210> 9
<211> 27
<212> PRT
<213> Artificial Sequence

<220>
<223> Description of Artificial Sequence: Synthetic
      peptide


<220>
<221> MOD_RES
<222> (1)..(27)
<223> D-amino acid

<220>
<221> MOD_RES
<222> (2)..(2)
<223> a (3,14,25-trihydroxy-2,10,13,21,24-pentaoxo-3,9,14,20,25
      -pentaazatriacontan-30-yl)amino group covalently associated by a
      bond or through a covalent linker with a heteroatom of a side
      chain of an amino acid residue of the peptide sequence, a

<220>
<221> MOD_RES
<222> (2)..(2)
<223> CONT. FROM ABOVE: (3,14,25,36-tetrahydroxy-2,10,13,21,24,32,35
      -heptaoxo-3,9,14,20,25,31,36-heptaazahentetracontan-41-yl)amino
      group covalently associated by a bond or through a covalent
      linker with a heteroatom of a side chain of an amino acid

<220>
<221> MOD_RES
<222> (2)..(2)
<223> CONT. FROM ABOVE: residue of the peptide sequence, or a 16-(1
      -hydroxy-6-oxo-1,6-dihydropyridin-2-yl)-2,6,11-tris(1-hydroxy
      -6-oxo-1,6-dihydropyridine-2-carbonyl)-16-oxo-2,6,11,15
      -tetraazahexadecyl group covalently associated by a bond or

<220>
<221> MOD_RES
<222> (2)..(2)
<223> CONT. FROM ABOVE: through a covalent linker with a heteroatom
      of a side chain of an amino acid residue of the peptide sequence

<220> 
<223> See specification as filed for detailed description of
      substitutions and preferred embodiments

<400> 9
Ala Cys Asp Asp Gln Asn Pro Trp Arg Ala Tyr Leu Asp Leu Leu Phe 
1               5                   10                  15      


Pro Thr Asp Thr Leu Leu Leu Asp Leu Leu Trp 
            20                  25          


<210> 10
<211> 27
<212> PRT
<213> Artificial Sequence

<220>
<223> Description of Artificial Sequence: Synthetic
      peptide


<220>
<221> MOD_RES
<222> (1)..(27)
<223> D-amino acid

<220>
<221> MOD_RES
<222> (2)..(2)
<223> a (3,14,25-trihydroxy-2,10,13,21,24-pentaoxo-3,9,14,20,25
      -pentaazatriacontan-30-yl)amino group covalently associated by a
      bond or through a covalent linker with a heteroatom of a side
      chain of an amino acid residue of the peptide sequence, a

<220>
<221> MOD_RES
<222> (2)..(2)
<223> CONT. FROM ABOVE: (3,14,25,36-tetrahydroxy-2,10,13,21,24,32,35
      -heptaoxo-3,9,14,20,25,31,36-heptaazahentetracontan-41-yl)amino
      group covalently associated by a bond or through a covalent
      linker with a heteroatom of a side chain of an amino acid

<220>
<221> MOD_RES
<222> (2)..(2)
<223> CONT. FROM ABOVE: residue of the peptide sequence, or a 16-(1
      -hydroxy-6-oxo-1,6-dihydropyridin-2-yl)-2,6,11-tris(1-hydroxy
      -6-oxo-1,6-dihydropyridine-2-carbonyl)-16-oxo-2,6,11,15
      -tetraazahexadecyl group covalently associated by a bond or

<220>
<221> MOD_RES
<222> (2)..(2)
<223> CONT. FROM ABOVE: through a covalent linker with a heteroatom
      of a side chain of an amino acid residue of the peptide sequence

<220> 
<223> See specification as filed for detailed description of
      substitutions and preferred embodiments

<400> 10
Ala Cys Asp Gln Asp Asn Pro Trp Arg Ala Tyr Leu Asp Leu Leu Phe 
1               5                   10                  15      


Pro Thr Asp Thr Leu Leu Leu Asp Leu Leu Trp 
            20                  25          


<210> 11
<211> 27
<212> PRT
<213> Artificial Sequence

<220>
<223> Description of Artificial Sequence: Synthetic
      peptide


<220>
<221> MOD_RES
<222> (1)..(27)
<223> D-amino acid

<220>
<221> MOD_RES
<222> (2)..(2)
<223> a (3,14,25-trihydroxy-2,10,13,21,24-pentaoxo-3,9,14,20,25
      -pentaazatriacontan-30-yl)amino group covalently associated by a
      bond or through a covalent linker with a heteroatom of a side
      chain of an amino acid residue of the peptide sequence, a

<220>
<221> MOD_RES
<222> (2)..(2)
<223> CONT. FROM ABOVE: (3,14,25,36-tetrahydroxy-2,10,13,21,24,32,35
      -heptaoxo-3,9,14,20,25,31,36-heptaazahentetracontan-41-yl)amino
      group covalently associated by a bond or through a covalent
      linker with a heteroatom of a side chain of an amino acid

<220>
<221> MOD_RES
<222> (2)..(2)
<223> CONT. FROM ABOVE: residue of the peptide sequence, or a 16-(1
      -hydroxy-6-oxo-1,6-dihydropyridin-2-yl)-2,6,11-tris(1-hydroxy
      -6-oxo-1,6-dihydropyridine-2-carbonyl)-16-oxo-2,6,11,15
      -tetraazahexadecyl group covalently associated by a bond or

<220>
<221> MOD_RES
<222> (2)..(2)
<223> CONT. FROM ABOVE: through a covalent linker with a heteroatom
      of a side chain of an amino acid residue of the peptide sequence

<220> 
<223> See specification as filed for detailed description of
      substitutions and preferred embodiments

<400> 11
Ala Lys Asp Asp Gln Asn Pro Trp Arg Ala Tyr Leu Asp Leu Leu Phe 
1               5                   10                  15      


Pro Thr Asp Thr Leu Leu Leu Asp Leu Leu Trp 
            20                  25          


<210> 12
<211> 27
<212> PRT
<213> Artificial Sequence

<220>
<223> Description of Artificial Sequence: Synthetic
      peptide


<220>
<221> MOD_RES
<222> (1)..(27)
<223> D-amino acid

<220>
<221> MOD_RES
<222> (2)..(2)
<223> a (3,14,25-trihydroxy-2,10,13,21,24-pentaoxo-3,9,14,20,25
      -pentaazatriacontan-30-yl)amino group covalently associated by a
      bond or through a covalent linker with a heteroatom of a side
      chain of an amino acid residue of the peptide sequence, a

<220>
<221> MOD_RES
<222> (2)..(2)
<223> CONT. FROM ABOVE: (3,14,25,36-tetrahydroxy-2,10,13,21,24,32,35
      -heptaoxo-3,9,14,20,25,31,36-heptaazahentetracontan-41-yl)amino
      group covalently associated by a bond or through a covalent
      linker with a heteroatom of a side chain of an amino acid

<220>
<221> MOD_RES
<222> (2)..(2)
<223> CONT. FROM ABOVE: residue of the peptide sequence, or a 16-(1
      -hydroxy-6-oxo-1,6-dihydropyridin-2-yl)-2,6,11-tris(1-hydroxy
      -6-oxo-1,6-dihydropyridine-2-carbonyl)-16-oxo-2,6,11,15
      -tetraazahexadecyl group covalently associated by a bond or

<220>
<221> MOD_RES
<222> (2)..(2)
<223> CONT. FROM ABOVE: through a covalent linker with a heteroatom
      of a side chain of an amino acid residue of the peptide sequence

<220> 
<223> See specification as filed for detailed description of
      substitutions and preferred embodiments

<400> 12
Ala Lys Asp Gln Asn Asn Pro Trp Arg Ala Tyr Leu Asp Leu Leu Phe 
1               5                   10                  15      


Pro Thr Asp Thr Leu Leu Leu Asp Leu Leu Trp 
            20                  25          


<210> 13
<211> 28
<212> PRT
<213> Artificial Sequence

<220>
<223> Description of Artificial Sequence: Synthetic
      peptide


<220>
<221> MOD_RES
<222> (1)..(27)
<223> D-amino acid

<220>
<221> MOD_RES
<222> (27)..(27)
<223> a (3,14,25-trihydroxy-2,10,13,21,24-pentaoxo-3,9,14,20,25
      -pentaazatriacontan-30-yl)amino group covalently associated by a
      bond or through a covalent linker with a heteroatom of a side
      chain of an amino acid residue of the peptide sequence, a

<220>
<221> MOD_RES
<222> (27)..(27)
<223> CONT. FROM ABOVE: (3,14,25,36-tetrahydroxy-2,10,13,21,24,32,35
      -heptaoxo-3,9,14,20,25,31,36-heptaazahentetracontan-41-yl)amino
      group covalently associated by a bond or through a covalent
      linker with a heteroatom of a side chain of an amino acid

<220>
<221> MOD_RES
<222> (27)..(27)
<223> CONT. FROM ABOVE: residue of the peptide sequence, or a 16-(1
      -hydroxy-6-oxo-1,6-dihydropyridin-2-yl)-2,6,11-tris(1-hydroxy
      -6-oxo-1,6-dihydropyridine-2-carbonyl)-16-oxo-2,6,11,15
      -tetraazahexadecyl group covalently associated by a bond or

<220>
<221> MOD_RES
<222> (27)..(27)
<223> CONT. FROM ABOVE: through a covalent linker with a heteroatom
      of a side chain of an amino acid residue of the peptide sequence

<220> 
<223> See specification as filed for detailed description of
      substitutions and preferred embodiments

<400> 13
Ala Asp Asp Gln Asn Pro Trp Arg Ala Tyr Leu Asp Leu Leu Phe Pro 
1               5                   10                  15      


Thr Asp Thr Leu Leu Leu Asp Leu Leu Trp Cys Gly 
            20                  25              


<210> 14
<211> 28
<212> PRT
<213> Artificial Sequence

<220>
<223> Description of Artificial Sequence: Synthetic
      peptide


<220>
<221> MOD_RES
<222> (1)..(27)
<223> D-amino acid

<220>
<221> MOD_RES
<222> (27)..(27)
<223> a (3,14,25-trihydroxy-2,10,13,21,24-pentaoxo-3,9,14,20,25
      -pentaazatriacontan-30-yl)amino group covalently associated by a
      bond or through a covalent linker with a heteroatom of a side
      chain of an amino acid residue of the peptide sequence, a

<220>
<221> MOD_RES
<222> (27)..(27)
<223> CONT. FROM ABOVE: (3,14,25,36-tetrahydroxy-2,10,13,21,24,32,35
      -heptaoxo-3,9,14,20,25,31,36-heptaazahentetracontan-41-yl)amino
      group covalently associated by a bond or through a covalent
      linker with a heteroatom of a side chain of an amino acid

<220>
<221> MOD_RES
<222> (27)..(27)
<223> CONT. FROM ABOVE: residue of the peptide sequence, or a 16-(1
      -hydroxy-6-oxo-1,6-dihydropyridin-2-yl)-2,6,11-tris(1-hydroxy
      -6-oxo-1,6-dihydropyridine-2-carbonyl)-16-oxo-2,6,11,15
      -tetraazahexadecyl group covalently associated by a bond or

<220>
<221> MOD_RES
<222> (27)..(27)
<223> CONT. FROM ABOVE: through a covalent linker with a heteroatom
      of a side chain of an amino acid residue of the peptide sequence

<220> 
<223> See specification as filed for detailed description of
      substitutions and preferred embodiments

<400> 14
Ala Asp Gln Asp Asn Pro Trp Arg Ala Tyr Leu Asp Leu Leu Phe Pro 
1               5                   10                  15      


Thr Asp Thr Leu Leu Leu Asp Leu Leu Trp Cys Gly 
            20                  25              


<210> 15
<211> 28
<212> PRT
<213> Artificial Sequence

<220>
<223> Description of Artificial Sequence: Synthetic
      peptide


<220>
<221> MOD_RES
<222> (1)..(27)
<223> D-amino acid

<220>
<221> MOD_RES
<222> (27)..(27)
<223> a (3,14,25-trihydroxy-2,10,13,21,24-pentaoxo-3,9,14,20,25
      -pentaazatriacontan-30-yl)amino group covalently associated by a
      bond or through a covalent linker with a heteroatom of a side
      chain of an amino acid residue of the peptide sequence, a

<220>
<221> MOD_RES
<222> (27)..(27)
<223> CONT. FROM ABOVE: (3,14,25,36-tetrahydroxy-2,10,13,21,24,32,35
      -heptaoxo-3,9,14,20,25,31,36-heptaazahentetracontan-41-yl)amino
      group covalently associated by a bond or through a covalent
      linker with a heteroatom of a side chain of an amino acid

<220>
<221> MOD_RES
<222> (27)..(27)
<223> CONT. FROM ABOVE: residue of the peptide sequence, or a 16-(1
      -hydroxy-6-oxo-1,6-dihydropyridin-2-yl)-2,6,11-tris(1-hydroxy
      -6-oxo-1,6-dihydropyridine-2-carbonyl)-16-oxo-2,6,11,15
      -tetraazahexadecyl group covalently associated by a bond or

<220>
<221> MOD_RES
<222> (27)..(27)
<223> CONT. FROM ABOVE: through a covalent linker with a heteroatom
      of a side chain of an amino acid residue of the peptide sequence

<220> 
<223> See specification as filed for detailed description of
      substitutions and preferred embodiments

<400> 15
Ala Asp Asp Gln Asn Pro Trp Arg Ala Tyr Leu Asp Leu Leu Phe Pro 
1               5                   10                  15      


Thr Asp Thr Leu Leu Leu Asp Leu Leu Trp Lys Gly 
            20                  25              


<210> 16
<211> 29
<212> PRT
<213> Artificial Sequence

<220>
<223> Description of Artificial Sequence: Synthetic
      peptide


<220>
<221> MOD_RES
<222> (1)..(28)
<223> D-amino acid

<220>
<221> MOD_RES
<222> (28)..(28)
<223> a (3,14,25-trihydroxy-2,10,13,21,24-pentaoxo-3,9,14,20,25
      -pentaazatriacontan-30-yl)amino group covalently associated by a
      bond or through a covalent linker with a heteroatom of a side
      chain of an amino acid residue of the peptide sequence, a

<220>
<221> MOD_RES
<222> (28)..(28)
<223> CONT. FROM ABOVE: (3,14,25,36-tetrahydroxy-2,10,13,21,24,32,35
      -heptaoxo-3,9,14,20,25,31,36-heptaazahentetracontan-41-yl)amino
      group covalently associated by a bond or through a covalent
      linker with a heteroatom of a side chain of an amino acid

<220>
<221> MOD_RES
<222> (28)..(28)
<223> CONT. FROM ABOVE: residue of the peptide sequence, or a 16-(1
      -hydroxy-6-oxo-1,6-dihydropyridin-2-yl)-2,6,11-tris(1-hydroxy
      -6-oxo-1,6-dihydropyridine-2-carbonyl)-16-oxo-2,6,11,15
      -tetraazahexadecyl group covalently associated by a bond or

<220>
<221> MOD_RES
<222> (28)..(28)
<223> CONT. FROM ABOVE: through a covalent linker with a heteroatom
      of a side chain of an amino acid residue of the peptide sequence

<220> 
<223> See specification as filed for detailed description of
      substitutions and preferred embodiments

<400> 16
Ala Lys Asp Gln Asn Asn Pro Trp Arg Ala Tyr Leu Asp Leu Leu Phe 
1               5                   10                  15      


Pro Thr Asp Thr Leu Leu Leu Asp Leu Leu Trp Lys Gly 
            20                  25                  


<210> 17
<211> 27
<212> PRT
<213> Artificial Sequence

<220>
<223> Description of Artificial Sequence: Synthetic
      peptide


<220>
<221> MOD_RES
<222> (1)..(27)
<223> D-amino acid

<220>
<221> MOD_RES
<222> (2)..(2)
<223> a (3,14,25-trihydroxy-2,10,13,21,24-pentaoxo-3,9,14,20,25
      -pentaazatriacontan-30-yl)amino group chelating a radionuclide
      where the group is covalently associated by a bond or through a
      covalent linker with a heteroatom of a side chain of an amino

<220>
<221> MOD_RES
<222> (2)..(2)
<223> CONT. FROM ABOVE: acid residue of the peptide sequence, a
      (3,14,25,36-tetrahydroxy-2,10,13,21,24,32,35-heptaoxo
      -3,9,14,20,25,31,36-heptaazahentetracontan-41-yl)amino group
      chelating a radionuclide where the group is covalently 

<220>
<221> MOD_RES
<222> (2)..(2)
<223> CONT. FROM ABOVE: associated by a bond or through a covalent
      linker with a heteroatom of a side chain of an amino acid
      residue of the peptide sequence, or a 16-(1-hydroxy-6-oxo-1,6
      -dihydropyridin-2-yl)-2,6,11-tris(1-hydroxy-6-oxo-1,6

<220>
<221> MOD_RES
<222> (2)..(2)
<223> CONT. FROM ABOVE: -dihydropyridine-2-carbonyl)-16-oxo-2,6,11,15
      -tetraazahexadecyl chelating a radionuclide where the group is
      group covalently associated by a bond or through a covalent
      linker with a heteroatom of a side chain of an amino acid

<220>
<221> MOD_RES
<222> (2)..(2)
<223> CONT. FROM ABOVE: residue of the peptide sequence

<220> 
<223> See specification as filed for detailed description of
      substitutions and preferred embodiments

<400> 17
Ala Cys Asp Asp Gln Asn Pro Trp Arg Ala Tyr Leu Asp Leu Leu Phe 
1               5                   10                  15      


Pro Thr Asp Thr Leu Leu Leu Asp Leu Leu Trp 
            20                  25          


<210> 18
<211> 27
<212> PRT
<213> Artificial Sequence

<220>
<223> Description of Artificial Sequence: Synthetic
      peptide


<220>
<221> MOD_RES
<222> (1)..(27)
<223> D-amino acid

<220>
<221> MOD_RES
<222> (2)..(2)
<223> a (3,14,25-trihydroxy-2,10,13,21,24-pentaoxo-3,9,14,20,25
      -pentaazatriacontan-30-yl)amino group chelating a radionuclide
      where the group is covalently associated by a bond or through a
      covalent linker with a heteroatom of a side chain of an amino

<220>
<221> MOD_RES
<222> (2)..(2)
<223> CONT. FROM ABOVE: acid residue of the peptide sequence, a
      (3,14,25,36-tetrahydroxy-2,10,13,21,24,32,35-heptaoxo
      -3,9,14,20,25,31,36-heptaazahentetracontan-41-yl)amino group
      chelating a radionuclide where the group is covalently

<220>
<221> MOD_RES
<222> (2)..(2)
<223> CONT. FROM ABOVE: associated by a bond or through a covalent 
      linker with a heteroatom of a side chain of an amino acid
      residue of the peptide sequence, or a 16-(1-hydroxy-6-oxo-1,6
      -dihydropyridin-2-yl)-2,6,11-tris(1-hydroxy-6-oxo-1,6

<220>
<221> MOD_RES
<222> (2)..(2)
<223> CONT. FROM ABOVE: -dihydropyridine-2-carbonyl)-16-oxo-2,6,11,15
      -tetraazahexadecyl chelating a radionuclide where the group is
      group covalently associated by a bond or through a covalent
      linker with a heteroatom of a side chain of an amino acid 

<220>
<221> MOD_RES
<222> (2)..(2)
<223> CONT. FROM ABOVE: residue of the peptide sequence

<220> 
<223> See specification as filed for detailed description of
      substitutions and preferred embodiments

<400> 18
Ala Cys Asp Gln Asp Asn Pro Trp Arg Ala Tyr Leu Asp Leu Leu Phe 
1               5                   10                  15      


Pro Thr Asp Thr Leu Leu Leu Asp Leu Leu Trp 
            20                  25          


<210> 19
<211> 27
<212> PRT
<213> Artificial Sequence

<220>
<223> Description of Artificial Sequence: Synthetic
      peptide


<220>
<221> MOD_RES
<222> (1)..(27)
<223> D-amino acid

<220>
<221> MOD_RES
<222> (2)..(2)
<223> a (3,14,25-trihydroxy-2,10,13,21,24-pentaoxo-3,9,14,20,25
      -pentaazatriacontan-30-yl)amino group chelating a radionuclide
      where the group is covalently associated by a bond or through a
      covalent linker with a heteroatom of a side chain of an amino

<220>
<221> MOD_RES
<222> (2)..(2)
<223> CONT. FROM ABOVE: acid residue of the peptide sequence, a
      (3,14,25,36-tetrahydroxy-2,10,13,21,24,32,35-heptaoxo
      -3,9,14,20,25,31,36-heptaazahentetracontan-41-yl)amino group
      chelating a radionuclide where the group is covalently

<220>
<221> MOD_RES
<222> (2)..(2)
<223> CONT. FROM ABOVE: associated by a bond or through a covalent 
      linker with a heteroatom of a side chain of an amino acid
      residue of the peptide sequence, or a 16-(1-hydroxy-6-oxo-1,6
      -dihydropyridin-2-yl)-2,6,11-tris(1-hydroxy-6-oxo-1,6

<220>
<221> MOD_RES
<222> (2)..(2)
<223> CONT. FROM ABOVE: -dihydropyridine-2-carbonyl)-16-oxo-2,6,11,15
      -tetraazahexadecyl chelating a radionuclide where the group is
      group covalently associated by a bond or through a covalent
      linker with a heteroatom of a side chain of an amino acid 

<220>
<221> MOD_RES
<222> (2)..(2)
<223> CONT. FROM ABOVE: residue of the peptide sequence

<220> 
<223> See specification as filed for detailed description of
      substitutions and preferred embodiments

<400> 19
Ala Lys Asp Asp Gln Asn Pro Trp Arg Ala Tyr Leu Asp Leu Leu Phe 
1               5                   10                  15      


Pro Thr Asp Thr Leu Leu Leu Asp Leu Leu Trp 
            20                  25          


<210> 20
<211> 27
<212> PRT
<213> Artificial Sequence

<220>
<223> Description of Artificial Sequence: Synthetic
      peptide


<220>
<221> MOD_RES
<222> (1)..(27)
<223> D-amino acid

<220>
<221> MOD_RES
<222> (2)..(2)
<223> a (3,14,25-trihydroxy-2,10,13,21,24-pentaoxo-3,9,14,20,25
      -pentaazatriacontan-30-yl)amino group chelating a radionuclide
      where the group is covalently associated by a bond or through a
      covalent linker with a heteroatom of a side chain of an amino

<220>
<221> MOD_RES
<222> (2)..(2)
<223> CONT. FROM ABOVE: acid residue of the peptide sequence, a
      (3,14,25,36-tetrahydroxy-2,10,13,21,24,32,35-heptaoxo
      -3,9,14,20,25,31,36-heptaazahentetracontan-41-yl)amino group
      chelating a radionuclide where the group is covalently

<220>
<221> MOD_RES
<222> (2)..(2)
<223> CONT. FROM ABOVE: associated by a bond or through a covalent 
      linker with a heteroatom of a side chain of an amino acid
      residue of the peptide sequence, or a 16-(1-hydroxy-6-oxo-1,6
      -dihydropyridin-2-yl)-2,6,11-tris(1-hydroxy-6-oxo-1,6

<220>
<221> MOD_RES
<222> (2)..(2)
<223> CONT. FROM ABOVE: -dihydropyridine-2-carbonyl)-16-oxo-2,6,11,15
      -tetraazahexadecyl chelating a radionuclide where the group is
      group covalently associated by a bond or through a covalent
      linker with a heteroatom of a side chain of an amino acid 

<220>
<221> MOD_RES
<222> (2)..(2)
<223> CONT. FROM ABOVE: residue of the peptide sequence

<220> 
<223> See specification as filed for detailed description of
      substitutions and preferred embodiments

<400> 20
Ala Lys Asp Gln Asn Asn Pro Trp Arg Ala Tyr Leu Asp Leu Leu Phe 
1               5                   10                  15      


Pro Thr Asp Thr Leu Leu Leu Asp Leu Leu Trp 
            20                  25          


<210> 21
<211> 28
<212> PRT
<213> Artificial Sequence

<220>
<223> Description of Artificial Sequence: Synthetic
      peptide


<220>
<221> MOD_RES
<222> (1)..(27)
<223> D-amino acid

<220>
<221> MOD_RES
<222> (27)..(27)
<223> a (3,14,25-trihydroxy-2,10,13,21,24-pentaoxo-3,9,14,20,25
      -pentaazatriacontan-30-yl)amino group chelating a radionuclide
      where the group is covalently associated by a bond or through a
      covalent linker with a heteroatom of a side chain of an amino

<220>
<221> MOD_RES
<222> (27)..(27)
<223> CONT. FROM ABOVE: acid residue of the peptide sequence, a
      (3,14,25,36-tetrahydroxy-2,10,13,21,24,32,35-heptaoxo
      -3,9,14,20,25,31,36-heptaazahentetracontan-41-yl)amino group
      chelating a radionuclide where the group is covalently

<220>
<221> MOD_RES
<222> (27)..(27)
<223> CONT. FROM ABOVE: associated by a bond or through a covalent 
      linker with a heteroatom of a side chain of an amino acid
      residue of the peptide sequence, or a 16-(1-hydroxy-6-oxo-1,6
      -dihydropyridin-2-yl)-2,6,11-tris(1-hydroxy-6-oxo-1,6

<220>
<221> MOD_RES
<222> (27)..(27)
<223> CONT. FROM ABOVE: -dihydropyridine-2-carbonyl)-16-oxo-2,6,11,15
      -tetraazahexadecyl chelating a radionuclide where the group is
      group covalently associated by a bond or through a covalent
      linker with a heteroatom of a side chain of an amino acid 

<220>
<221> MOD_RES
<222> (27)..(27)
<223> CONT. FROM ABOVE: residue of the peptide sequence

<220> 
<223> See specification as filed for detailed description of
      substitutions and preferred embodiments

<400> 21
Ala Asp Asp Gln Asn Pro Trp Arg Ala Tyr Leu Asp Leu Leu Phe Pro 
1               5                   10                  15      


Thr Asp Thr Leu Leu Leu Asp Leu Leu Trp Cys Gly 
            20                  25              


<210> 22
<211> 28
<212> PRT
<213> Artificial Sequence

<220>
<223> Description of Artificial Sequence: Synthetic
      peptide


<220>
<221> MOD_RES
<222> (1)..(27)
<223> D-amino acid

<220>
<221> MOD_RES
<222> (27)..(27)
<223> a (3,14,25-trihydroxy-2,10,13,21,24-pentaoxo-3,9,14,20,25
      -pentaazatriacontan-30-yl)amino group chelating a radionuclide
      where the group is covalently associated by a bond or through a
      covalent linker with a heteroatom of a side chain of an amino

<220>
<221> MOD_RES
<222> (27)..(27)
<223> CONT. FROM ABOVE: acid residue of the peptide sequence, a
      (3,14,25,36-tetrahydroxy-2,10,13,21,24,32,35-heptaoxo
      -3,9,14,20,25,31,36-heptaazahentetracontan-41-yl)amino group
      chelating a radionuclide where the group is covalently

<220>
<221> MOD_RES
<222> (27)..(27)
<223> CONT. FROM ABOVE: associated by a bond or through a covalent 
      linker with a heteroatom of a side chain of an amino acid
      residue of the peptide sequence, or a 16-(1-hydroxy-6-oxo-1,6
      -dihydropyridin-2-yl)-2,6,11-tris(1-hydroxy-6-oxo-1,6

<220>
<221> MOD_RES
<222> (27)..(27)
<223> CONT. FROM ABOVE: -dihydropyridine-2-carbonyl)-16-oxo-2,6,11,15
      -tetraazahexadecyl chelating a radionuclide where the group is
      group covalently associated by a bond or through a covalent
      linker with a heteroatom of a side chain of an amino acid 

<220>
<221> MOD_RES
<222> (27)..(27)
<223> CONT. FROM ABOVE: residue of the peptide sequence

<220> 
<223> See specification as filed for detailed description of
      substitutions and preferred embodiments

<400> 22
Ala Asp Gln Asp Asn Pro Trp Arg Ala Tyr Leu Asp Leu Leu Phe Pro 
1               5                   10                  15      


Thr Asp Thr Leu Leu Leu Asp Leu Leu Trp Cys Gly 
            20                  25              


<210> 23
<211> 28
<212> PRT
<213> Artificial Sequence

<220>
<223> Description of Artificial Sequence: Synthetic
      peptide


<220>
<221> MOD_RES
<222> (1)..(27)
<223> D-amino acid

<220>
<221> MOD_RES
<222> (27)..(27)
<223> a (3,14,25-trihydroxy-2,10,13,21,24-pentaoxo-3,9,14,20,25
      -pentaazatriacontan-30-yl)amino group chelating a radionuclide
      where the group is covalently associated by a bond or through a
      covalent linker with a heteroatom of a side chain of an amino

<220>
<221> MOD_RES
<222> (27)..(27)
<223> CONT. FROM ABOVE: acid residue of the peptide sequence, a
      (3,14,25,36-tetrahydroxy-2,10,13,21,24,32,35-heptaoxo
      -3,9,14,20,25,31,36-heptaazahentetracontan-41-yl)amino group
      chelating a radionuclide where the group is covalently

<220>
<221> MOD_RES
<222> (27)..(27)
<223> CONT. FROM ABOVE: associated by a bond or through a covalent 
      linker with a heteroatom of a side chain of an amino acid
      residue of the peptide sequence, or a 16-(1-hydroxy-6-oxo-1,6
      -dihydropyridin-2-yl)-2,6,11-tris(1-hydroxy-6-oxo-1,6

<220>
<221> MOD_RES
<222> (27)..(27)
<223> CONT. FROM ABOVE: -dihydropyridine-2-carbonyl)-16-oxo-2,6,11,15
      -tetraazahexadecyl chelating a radionuclide where the group is
      group covalently associated by a bond or through a covalent
      linker with a heteroatom of a side chain of an amino acid 

<220>
<221> MOD_RES
<222> (27)..(27)
<223> CONT. FROM ABOVE: residue of the peptide sequence

<220> 
<223> See specification as filed for detailed description of
      substitutions and preferred embodiments

<400> 23
Ala Asp Asp Gln Asn Pro Trp Arg Ala Tyr Leu Asp Leu Leu Phe Pro 
1               5                   10                  15      


Thr Asp Thr Leu Leu Leu Asp Leu Leu Trp Lys Gly 
            20                  25              


<210> 24
<211> 29
<212> PRT
<213> Artificial Sequence

<220>
<223> Description of Artificial Sequence: Synthetic
      peptide


<220>
<221> MOD_RES
<222> (1)..(28)
<223> D-amino acid

<220>
<221> MOD_RES
<222> (28)..(28)
<223> a (3,14,25-trihydroxy-2,10,13,21,24-pentaoxo-3,9,14,20,25
      -pentaazatriacontan-30-yl)amino group chelating a radionuclide
      where the group is covalently associated by a bond or through a
      covalent linker with a heteroatom of a side chain of an amino

<220>
<221> MOD_RES
<222> (28)..(28)
<223> CONT. FROM ABOVE: acid residue of the peptide sequence, a
      (3,14,25,36-tetrahydroxy-2,10,13,21,24,32,35-heptaoxo
      -3,9,14,20,25,31,36-heptaazahentetracontan-41-yl)amino group
      chelating a radionuclide where the group is covalently

<220>
<221> MOD_RES
<222> (28)..(28)
<223> CONT. FROM ABOVE: associated by a bond or through a covalent 
      linker with a heteroatom of a side chain of an amino acid
      residue of the peptide sequence, or a 16-(1-hydroxy-6-oxo-1,6
      -dihydropyridin-2-yl)-2,6,11-tris(1-hydroxy-6-oxo-1,6

<220>
<221> MOD_RES
<222> (28)..(28)
<223> CONT. FROM ABOVE: -dihydropyridine-2-carbonyl)-16-oxo-2,6,11,15
      -tetraazahexadecyl chelating a radionuclide where the group is
      group covalently associated by a bond or through a covalent
      linker with a heteroatom of a side chain of an amino acid 

<220>
<221> MOD_RES
<222> (28)..(28)
<223> CONT. FROM ABOVE: residue of the peptide sequence

<220> 
<223> See specification as filed for detailed description of
      substitutions and preferred embodiments

<400> 24
Ala Lys Asp Gln Asn Asn Pro Trp Arg Ala Tyr Leu Asp Leu Leu Phe 
1               5                   10                  15      


Pro Thr Asp Thr Leu Leu Leu Asp Leu Leu Trp Lys Gly 
            20                  25                  


<210> 25
<211> 27
<212> PRT
<213> Artificial Sequence

<220>
<223> Description of Artificial Sequence: Synthetic
      peptide


<220>
<221> MOD_RES
<222> (1)..(27)
<223> D-amino acid

<220>
<221> MOD_RES
<222> (2)..(2)
<223> 2,5-dioxo-1-(3,14,25-trihydroxy-2,10,13,21,24,32-hexaoxo
      -3,9,14,20,25,31-hexaazatetratriacontan-34-yl)pyrrolidin-3-yl
      covalently attached to the sulfur atom of the indicated
      D-cysteine

<220> 
<223> See specification as filed for detailed description of
      substitutions and preferred embodiments

<400> 25
Ala Cys Asp Asp Gln Asn Pro Trp Arg Ala Tyr Leu Asp Leu Leu Phe 
1               5                   10                  15      


Pro Thr Asp Thr Leu Leu Leu Asp Leu Leu Trp 
            20                  25          


<210> 26
<211> 28
<212> PRT
<213> Artificial Sequence

<220>
<223> Description of Artificial Sequence: Synthetic
      peptide

<400> 26
Ala Asp Gln Asp Asn Pro Trp Arg Ala Tyr Leu Asp Leu Leu Phe Pro 
1               5                   10                  15      


Thr Asp Thr Leu Leu Leu Asp Leu Leu Trp Cys Ala 
            20                  25              


<210> 27
<211> 28
<212> PRT
<213> Artificial Sequence

<220>
<223> Description of Artificial Sequence: Synthetic
      peptide

<400> 27
Ala Asp Gln Asp Asn Pro Trp Arg Ala Tyr Leu Asp Leu Leu Phe Pro 
1               5                   10                  15      


Thr Asp Thr Leu Leu Leu Asp Leu Leu Trp Lys Ala 
            20                  25              


<210> 28
<211> 36
<212> PRT
<213> Artificial Sequence

<220>
<223> Description of Artificial Sequence: Synthetic
      polypeptide

<400> 28
Gly Gly Glu Gln Asn Pro Ile Tyr Trp Ala Arg Tyr Ala Asp Trp Leu 
1               5                   10                  15      


Phe Thr Thr Pro Leu Leu Leu Leu Asp Leu Ala Leu Leu Val Asp Ala 
            20                  25                  30          


Asp Glu Gly Thr 
        35      


<210> 29
<211> 35
<212> PRT
<213> Artificial Sequence

<220>
<223> Description of Artificial Sequence: Synthetic
      polypeptide

<400> 29
Ala Glu Gln Asn Pro Ile Tyr Trp Ala Arg Tyr Ala Asp Trp Leu Phe 
1               5                   10                  15      


Thr Thr Pro Leu Leu Leu Leu Asp Leu Ala Leu Leu Val Asp Ala Asp 
            20                  25                  30          


Glu Gly Thr 
        35  


<210> 30
<211> 29
<212> PRT
<213> Artificial Sequence

<220>
<223> Description of Artificial Sequence: Synthetic
      peptide

<400> 30
Ala Asp Asp Gln Asn Pro Trp Arg Ala Tyr Leu Asp Leu Leu Phe Pro 
1               5                   10                  15      


Thr Asp Thr Leu Leu Leu Asp Leu Leu Trp Cys Lys Ala 
            20                  25                  


<210> 31
<211> 32
<212> PRT
<213> Artificial Sequence

<220>
<223> Description of Artificial Sequence: Synthetic
      polypeptide

<400> 31
Ala Asp Asp Gln Asn Pro Trp Arg Ala Tyr Leu Asp Leu Leu Phe Pro 
1               5                   10                  15      


Thr Asp Thr Leu Leu Leu Asp Leu Leu Trp Asp Ala Asp Glu Cys Gly 
            20                  25                  30          


<210> 32
<211> 32
<212> PRT
<213> Artificial Sequence

<220>
<223> Description of Artificial Sequence: Synthetic
      polypeptide

<400> 32
Ala Asp Asp Gln Asn Pro Trp Arg Ala Tyr Leu Asp Leu Leu Phe Pro 
1               5                   10                  15      


Thr Asp Thr Leu Leu Leu Asp Leu Leu Trp Asp Ala Asp Glu Lys Gly 
            20                  25                  30          


<210> 33
<211> 33
<212> PRT
<213> Artificial Sequence

<220>
<223> Description of Artificial Sequence: Synthetic
      polypeptide

<400> 33
Ala Asp Asp Gln Asn Pro Trp Arg Ala Tyr Leu Asp Leu Leu Phe Pro 
1               5                   10                  15      


Thr Asp Thr Leu Leu Leu Asp Leu Leu Trp Asp Ala Asp Glu Lys Cys 
            20                  25                  30          


Gly 
    


<210> 34
<211> 32
<212> PRT
<213> Artificial Sequence

<220>
<223> Description of Artificial Sequence: Synthetic
      polypeptide

<400> 34
Ala Cys Asp Asp Gln Asn Pro Trp Arg Ala Tyr Leu Asp Leu Leu Phe 
1               5                   10                  15      


Pro Thr Asp Thr Leu Leu Leu Asp Leu Leu Trp Asp Ala Asp Glu Gly 
            20                  25                  30          


<210> 35
<211> 32
<212> PRT
<213> Artificial Sequence

<220>
<223> Description of Artificial Sequence: Synthetic
      polypeptide

<400> 35
Ala Lys Asp Asp Gln Asn Pro Trp Arg Ala Tyr Leu Asp Leu Leu Phe 
1               5                   10                  15      


Pro Thr Asp Thr Leu Leu Leu Asp Leu Leu Trp Asp Ala Asp Glu Gly 
            20                  25                  30          


<210> 36
<211> 38
<212> PRT
<213> Artificial Sequence

<220>
<223> Description of Artificial Sequence: Synthetic
      polypeptide

<400> 36
Ala Ala Glu Gln Asn Pro Ile Tyr Trp Ala Arg Tyr Ala Asp Trp Leu 
1               5                   10                  15      


Phe Thr Thr Pro Leu Leu Leu Leu Asp Leu Ala Leu Leu Val Asp Ala 
            20                  25                  30          


Asp Glu Gly Thr Cys Gly 
        35              


<210> 37
<211> 36
<212> PRT
<213> Artificial Sequence

<220>
<223> Description of Artificial Sequence: Synthetic
      polypeptide

<400> 37
Ala Glu Gln Asn Pro Ile Tyr Trp Ala Arg Tyr Ala Asp Trp Leu Phe 
1               5                   10                  15      


Thr Thr Pro Leu Leu Leu Leu Asp Leu Ala Leu Leu Val Asp Ala Asp 
            20                  25                  30          


Glu Gly Cys Thr 
        35      


<210> 38
<211> 38
<212> PRT
<213> Artificial Sequence

<220>
<223> Description of Artificial Sequence: Synthetic
      polypeptide

<400> 38
Gly Gly Glu Gln Asn Pro Ile Tyr Trp Ala Arg Tyr Ala Asp Trp Leu 
1               5                   10                  15      


Phe Thr Thr Pro Leu Leu Leu Leu Asp Leu Ala Leu Leu Val Asp Ala 
            20                  25                  30          


Asp Glu Gly Thr Cys Gly 
        35              


<210> 39
<211> 37
<212> PRT
<213> Artificial Sequence

<220>
<223> Description of Artificial Sequence: Synthetic
      polypeptide

<400> 39
Ala Cys Glu Gln Asn Pro Ile Tyr Trp Ala Arg Tyr Ala Asp Trp Leu 
1               5                   10                  15      


Phe Thr Thr Pro Leu Leu Leu Leu Asp Leu Ala Leu Leu Val Asp Ala 
            20                  25                  30          


Asp Glu Gly Thr Gly 
        35          


<210> 40
<211> 36
<212> PRT
<213> Artificial Sequence

<220>
<223> Description of Artificial Sequence: Synthetic
      polypeptide

<400> 40
Ala Cys Glu Gln Asn Pro Ile Tyr Trp Ala Arg Tyr Ala Asp Trp Leu 
1               5                   10                  15      


Phe Thr Thr Pro Leu Leu Leu Leu Asp Leu Ala Leu Leu Val Asp Ala 
            20                  25                  30          


Asp Glu Gly Thr 
        35      


<210> 41
<211> 36
<212> PRT
<213> Artificial Sequence

<220>
<223> Description of Artificial Sequence: Synthetic
      polypeptide

<400> 41
Ala Lys Glu Gln Asn Pro Ile Tyr Trp Ala Arg Tyr Ala Asp Trp Leu 
1               5                   10                  15      


Phe Thr Thr Pro Leu Leu Leu Leu Asp Leu Ala Leu Leu Val Asp Ala 
            20                  25                  30          


Asp Glu Gly Thr 
        35      


<210> 42
<211> 37
<212> PRT
<213> Artificial Sequence

<220>
<223> Description of Artificial Sequence: Synthetic
      polypeptide

<400> 42
Ala Lys Glu Gln Asn Pro Ile Tyr Trp Ala Arg Tyr Ala Asp Trp Leu 
1               5                   10                  15      


Phe Thr Thr Pro Leu Leu Leu Leu Asp Leu Ala Leu Leu Val Asp Ala 
            20                  25                  30          


Asp Glu Gly Thr Gly 
        35          


<210> 43
<211> 39
<212> PRT
<213> Artificial Sequence

<220>
<223> Description of Artificial Sequence: Synthetic
      polypeptide

<400> 43
Ala Ala Glu Gln Asn Pro Ile Tyr Trp Ala Arg Tyr Ala Asp Trp Leu 
1               5                   10                  15      


Phe Thr Thr Pro Leu Leu Leu Leu Asp Leu Ala Leu Leu Val Asp Ala 
            20                  25                  30          


Asp Glu Gly Thr Lys Cys Gly 
        35                  


<210> 44
<211> 36
<212> PRT
<213> Artificial Sequence

<220>
<223> Description of Artificial Sequence: Synthetic
      polypeptide

<400> 44
Ala Lys Glu Gln Asn Pro Ile Tyr Trp Ala Arg Tyr Ala Asp Trp Leu 
1               5                   10                  15      


Phe Thr Thr Pro Leu Leu Leu Leu Asp Leu Ala Leu Leu Val Asp Ala 
            20                  25                  30          


Asp Glu Cys Thr 
        35      


<210> 45
<211> 37
<212> PRT
<213> Artificial Sequence

<220>
<223> Description of Artificial Sequence: Synthetic
      polypeptide

<400> 45
Ala Cys Glu Gln Asn Pro Ile Tyr Trp Ala Arg Tyr Ala Asn Trp Leu 
1               5                   10                  15      


Phe Thr Thr Pro Leu Leu Leu Leu Asn Leu Ala Leu Leu Val Asp Ala 
            20                  25                  30          


Asp Glu Gly Thr Gly 
        35          


<210> 46
<211> 36
<212> PRT
<213> Artificial Sequence

<220>
<223> Description of Artificial Sequence: Synthetic
      polypeptide

<400> 46
Ala Cys Glu Gln Asn Pro Ile Tyr Trp Ala Arg Tyr Ala Asn Trp Leu 
1               5                   10                  15      


Phe Thr Thr Pro Leu Leu Leu Leu Asn Leu Ala Leu Leu Val Asp Ala 
            20                  25                  30          


Asp Glu Gly Thr 
        35      


<210> 47
<211> 37
<212> PRT
<213> Artificial Sequence

<220>
<223> Description of Artificial Sequence: Synthetic
      polypeptide

<400> 47
Ala Cys Glu Gln Asn Pro Ile Tyr Trp Ala Arg Tyr Ala Lys Trp Leu 
1               5                   10                  15      


Phe Thr Thr Pro Leu Leu Leu Leu Lys Leu Ala Leu Leu Val Asp Ala 
            20                  25                  30          


Asp Glu Gly Thr Gly 
        35          


<210> 48
<211> 36
<212> PRT
<213> Artificial Sequence

<220>
<223> Description of Artificial Sequence: Synthetic
      polypeptide

<400> 48
Gly Gly Glu Gln Asn Pro Ile Tyr Trp Ala Arg Tyr Ala Asp Trp Leu 
1               5                   10                  15      


Phe Thr Thr Pro Leu Leu Leu Leu Asp Leu Ala Leu Leu Val Asn Ala 
            20                  25                  30          


Asn Gln Gly Thr 
        35      


<210> 49
<211> 36
<212> PRT
<213> Artificial Sequence

<220>
<223> Description of Artificial Sequence: Synthetic
      polypeptide

<400> 49
Ala Ala Glu Gln Asn Pro Ile Tyr Trp Ala Arg Tyr Ala Asp Trp Leu 
1               5                   10                  15      


Phe Thr Thr Pro Leu Leu Leu Leu Ala Leu Ala Leu Leu Val Asp Ala 
            20                  25                  30          


Asp Glu Gly Thr 
        35      


<210> 50
<211> 39
<212> PRT
<213> Artificial Sequence

<220>
<223> Description of Artificial Sequence: Synthetic
      polypeptide

<400> 50
Ala Ala Glu Gln Asn Pro Ile Tyr Trp Ala Arg Tyr Ala Asp Trp Leu 
1               5                   10                  15      


Phe Thr Thr Pro Leu Leu Leu Leu Glu Leu Ala Leu Leu Val Asp Ala 
            20                  25                  30          


Asp Glu Gly Thr Lys Cys Gly 
        35                  


<210> 51
<211> 36
<212> PRT
<213> Artificial Sequence

<220>
<223> Description of Artificial Sequence: Synthetic
      polypeptide

<400> 51
Ala Ala Glu Gln Asn Pro Ile Tyr Trp Ala Arg Tyr Ala Ala Trp Leu 
1               5                   10                  15      


Phe Thr Thr Pro Leu Leu Leu Leu Asp Leu Ala Leu Leu Val Asp Ala 
            20                  25                  30          


Asp Glu Gly Thr 
        35      


<210> 52
<211> 36
<212> PRT
<213> Artificial Sequence

<220>
<223> Description of Artificial Sequence: Synthetic
      polypeptide

<400> 52
Ala Ala Glu Gln Asn Pro Ile Tyr Trp Ala Arg Tyr Ala Asp Trp Leu 
1               5                   10                  15      


Phe Thr Thr Ala Leu Leu Leu Leu Asp Leu Ala Leu Leu Val Asp Ala 
            20                  25                  30          


Asp Glu Gly Thr 
        35      


<210> 53
<211> 36
<212> PRT
<213> Artificial Sequence

<220>
<223> Description of Artificial Sequence: Synthetic
      polypeptide

<400> 53
Ala Ala Glu Gln Asn Pro Ile Tyr Trp Ala Arg Tyr Ala Asp Trp Leu 
1               5                   10                  15      


Phe Thr Thr Pro Leu Leu Leu Leu Glu Leu Ala Leu Leu Val Asp Ala 
            20                  25                  30          


Asp Glu Gly Thr 
        35      


<210> 54
<211> 36
<212> PRT
<213> Artificial Sequence

<220>
<223> Description of Artificial Sequence: Synthetic
      polypeptide

<400> 54
Ala Ala Glu Gln Asn Pro Ile Tyr Trp Ala Arg Tyr Ala Glu Trp Leu 
1               5                   10                  15      


Phe Thr Thr Pro Leu Leu Leu Leu Asp Leu Ala Leu Leu Val Asp Ala 
            20                  25                  30          


Asp Glu Gly Thr 
        35      


<210> 55
<211> 39
<212> PRT
<213> Artificial Sequence

<220>
<223> Description of Artificial Sequence: Synthetic
      polypeptide

<400> 55
Ala Ala Glu Gln Asn Pro Ile Ile Tyr Trp Ala Arg Tyr Ala Asp Trp 
1               5                   10                  15      


Leu Phe Thr Asp Leu Pro Leu Leu Leu Leu Asp Leu Leu Ala Leu Leu 
            20                  25                  30          


Val Asp Ala Asp Glu Gly Thr 
        35                  


<210> 56
<211> 37
<212> PRT
<213> Artificial Sequence

<220>
<223> Description of Artificial Sequence: Synthetic
      polypeptide

<400> 56
Gly Glu Gln Asn Pro Ile Tyr Trp Ala Gln Tyr Ala Asp Trp Leu Phe 
1               5                   10                  15      


Thr Thr Pro Leu Leu Leu Leu Asp Leu Ala Leu Leu Val Asp Ala Asp 
            20                  25                  30          


Glu Gly Thr Cys Gly 
        35          


<210> 57
<211> 38
<212> PRT
<213> Artificial Sequence

<220>
<223> Description of Artificial Sequence: Synthetic
      polypeptide

<400> 57
Gly Gly Glu Gln Asn Pro Ile Tyr Trp Ala Arg Tyr Ala Asp Trp Leu 
1               5                   10                  15      


Phe Thr Thr Pro Leu Leu Leu Asp Leu Leu Ala Leu Leu Val Asp Ala 
            20                  25                  30          


Asp Glu Gly Thr Cys Gly 
        35              


<210> 58
<211> 38
<212> PRT
<213> Artificial Sequence

<220>
<223> Description of Artificial Sequence: Synthetic
      polypeptide

<400> 58
Gly Gly Glu Gln Asn Pro Ile Tyr Trp Ala Arg Tyr Ala Asp Trp Leu 
1               5                   10                  15      


Phe Thr Thr Pro Leu Leu Leu Leu Leu Asp Ala Leu Leu Val Asp Ala 
            20                  25                  30          


Asp Glu Gly Thr Cys Gly 
        35              


<210> 59
<211> 38
<212> PRT
<213> Artificial Sequence

<220>
<223> Description of Artificial Sequence: Synthetic
      polypeptide

<400> 59
Gly Gly Glu Gln Asn Pro Ile Tyr Trp Ala Arg Tyr Asp Ala Trp Leu 
1               5                   10                  15      


Phe Thr Thr Pro Leu Leu Leu Leu Asp Leu Ala Leu Leu Val Asp Ala 
            20                  25                  30          


Asp Glu Gly Thr Cys Gly 
        35              


<210> 60
<211> 38
<212> PRT
<213> Artificial Sequence

<220>
<223> Description of Artificial Sequence: Synthetic
      polypeptide

<400> 60
Gly Gly Glu Gln Asn Pro Ile Tyr Trp Ala Arg Tyr Ala Trp Asp Leu 
1               5                   10                  15      


Phe Thr Thr Pro Leu Leu Leu Leu Asp Leu Ala Leu Leu Val Asp Ala 
            20                  25                  30          


Asp Glu Gly Thr Cys Gly 
        35              


<210> 61
<211> 36
<212> PRT
<213> Artificial Sequence

<220>
<223> Description of Artificial Sequence: Synthetic
      polypeptide

<400> 61
Ala Ala Glu Gln Asn Pro Ile Tyr Trp Ala Arg Tyr Ala Asp Trp Leu 
1               5                   10                  15      


Phe Thr Thr Gly Leu Leu Leu Leu Asp Leu Ala Leu Leu Val Asp Ala 
            20                  25                  30          


Asp Glu Gly Thr 
        35      


<210> 62
<211> 37
<212> PRT
<213> Artificial Sequence

<220>
<223> Description of Artificial Sequence: Synthetic
      polypeptide

<400> 62
Asp Asp Asp Glu Asp Asn Pro Ile Tyr Trp Ala Arg Tyr Ala Asp Trp 
1               5                   10                  15      


Leu Phe Thr Thr Pro Leu Leu Leu Leu His Gly Ala Leu Leu Val Asp 
            20                  25                  30          


Ala Asp Glu Cys Thr 
        35          


<210> 63
<211> 36
<212> PRT
<213> Artificial Sequence

<220>
<223> Description of Artificial Sequence: Synthetic
      polypeptide

<400> 63
Asp Asp Asp Glu Asp Asn Pro Ile Tyr Trp Ala Arg Tyr Ala Asp Trp 
1               5                   10                  15      


Leu Phe Thr Thr Pro Leu Leu Leu Leu His Gly Ala Leu Leu Val Asp 
            20                  25                  30          


Ala Asp Glu Thr 
        35      


<210> 64
<211> 38
<212> PRT
<213> Artificial Sequence

<220>
<223> Description of Artificial Sequence: Synthetic
      polypeptide

<400> 64
Asp Asp Asp Glu Asp Asn Pro Ile Tyr Trp Ala Arg Tyr Ala His Trp 
1               5                   10                  15      


Leu Phe Thr Thr Pro Leu Leu Leu Leu His Gly Ala Leu Leu Val Asp 
            20                  25                  30          


Ala Asp Glu Gly Cys Thr 
        35              


<210> 65
<211> 37
<212> PRT
<213> Artificial Sequence

<220>
<223> Description of Artificial Sequence: Synthetic
      polypeptide

<400> 65
Cys Asp Asp Asp Glu Asp Asn Pro Ile Tyr Trp Ala Arg Tyr Ala His 
1               5                   10                  15      


Trp Leu Phe Thr Thr Pro Leu Leu Leu Leu His Gly Ala Leu Leu Val 
            20                  25                  30          


Asp Ala Asp Glu Thr 
        35          


<210> 66
<211> 37
<212> PRT
<213> Artificial Sequence

<220>
<223> Description of Artificial Sequence: Synthetic
      polypeptide

<400> 66
Asp Asp Asp Glu Asp Asn Pro Ile Tyr Trp Ala Arg Tyr Ala His Trp 
1               5                   10                  15      


Leu Phe Thr Thr Pro Leu Leu Leu Leu His Gly Ala Leu Leu Val Asp 
            20                  25                  30          


Ala Asp Glu Gly Thr 
        35          


<210> 67
<211> 37
<212> PRT
<213> Artificial Sequence

<220>
<223> Description of Artificial Sequence: Synthetic
      polypeptide

<400> 67
Asp Asp Asp Glu Asp Asn Pro Ile Tyr Trp Ala Arg Tyr Ala His Trp 
1               5                   10                  15      


Leu Phe Thr Thr Pro Leu Leu Leu Leu His Gly Ala Leu Leu Val Asn 
            20                  25                  30          


Ala Asp Glu Cys Thr 
        35          


<210> 68
<211> 37
<212> PRT
<213> Artificial Sequence

<220>
<223> Description of Artificial Sequence: Synthetic
      polypeptide

<400> 68
Asp Asp Asp Glu Asp Asn Pro Ile Tyr Trp Ala Arg Tyr Ala His Trp 
1               5                   10                  15      


Leu Phe Thr Thr Pro Leu Leu Leu Leu His Gly Ala Leu Leu Val Asn 
            20                  25                  30          


Ala Asp Glu Gly Thr 
        35          


<210> 69
<211> 37
<212> PRT
<213> Artificial Sequence

<220>
<223> Description of Artificial Sequence: Synthetic
      polypeptide

<400> 69
Asp Asp Asp Glu Asp Asn Pro Ile Tyr Trp Ala Arg Tyr Ala His Trp 
1               5                   10                  15      


Leu Phe Thr Thr Pro Leu Leu Leu Leu His Gly Ala Leu Leu Val Asn 
            20                  25                  30          


Ala Asn Glu Cys Thr 
        35          


<210> 70
<211> 37
<212> PRT
<213> Artificial Sequence

<220>
<223> Description of Artificial Sequence: Synthetic
      polypeptide

<400> 70
Asp Asp Asp Glu Asp Asn Pro Ile Tyr Trp Ala Arg Tyr Ala His Trp 
1               5                   10                  15      


Leu Phe Thr Thr Pro Leu Leu Leu Leu His Gly Ala Leu Leu Val Asn 
            20                  25                  30          


Ala Asn Glu Gly Thr 
        35          


<210> 71
<211> 34
<212> PRT
<213> Artificial Sequence

<220>
<223> Description of Artificial Sequence: Synthetic
      polypeptide

<400> 71
Ala Glu Gln Asn Pro Ile Tyr Trp Ala Arg Tyr Ala Asp Phe Leu Phe 
1               5                   10                  15      


Thr Thr Pro Leu Leu Leu Leu Asp Leu Ala Leu Leu Val Asp Ala Asp 
            20                  25                  30          


Glu Thr 
        


<210> 72
<211> 35
<212> PRT
<213> Artificial Sequence

<220>
<223> Description of Artificial Sequence: Synthetic
      polypeptide

<400> 72
Ala Glu Gln Asn Pro Ile Tyr Phe Ala Arg Tyr Ala Asp Trp Leu Phe 
1               5                   10                  15      


Thr Thr Pro Leu Leu Leu Leu Asp Leu Ala Leu Leu Val Asp Ala Asp 
            20                  25                  30          


Glu Gly Thr 
        35  


<210> 73
<211> 34
<212> PRT
<213> Artificial Sequence

<220>
<223> Description of Artificial Sequence: Synthetic
      polypeptide

<400> 73
Ala Glu Gln Asn Pro Ile Tyr Phe Ala Arg Tyr Ala Asp Phe Leu Phe 
1               5                   10                  15      


Thr Thr Pro Leu Leu Leu Leu Asp Leu Ala Leu Leu Trp Asp Ala Asp 
            20                  25                  30          


Glu Thr 
        


<210> 74
<211> 32
<212> PRT
<213> Artificial Sequence

<220>
<223> Description of Artificial Sequence: Synthetic
      polypeptide

<400> 74
Ala Lys Glu Asp Gln Asn Pro Tyr Trp Ala Arg Tyr Ala Asp Trp Leu 
1               5                   10                  15      


Phe Thr Thr Pro Leu Leu Leu Leu Asp Leu Ala Leu Leu Val Asp Gly 
            20                  25                  30          


<210> 75
<211> 32
<212> PRT
<213> Artificial Sequence

<220>
<223> Description of Artificial Sequence: Synthetic
      polypeptide

<400> 75
Ala Cys Glu Asp Gln Asn Pro Tyr Trp Ala Arg Tyr Ala Asp Trp Leu 
1               5                   10                  15      


Phe Thr Thr Pro Leu Leu Leu Leu Asp Leu Ala Leu Leu Val Asp Gly 
            20                  25                  30          


<210> 76
<211> 32
<212> PRT
<213> Artificial Sequence

<220>
<223> Description of Artificial Sequence: Synthetic
      polypeptide

<400> 76
Ala Glu Asp Gln Asn Pro Tyr Trp Ala Arg Tyr Ala Asp Trp Leu Phe 
1               5                   10                  15      


Thr Thr Pro Leu Leu Leu Leu Asp Leu Ala Leu Leu Val Asp Cys Gly 
            20                  25                  30          


<210> 77
<211> 32
<212> PRT
<213> Artificial Sequence

<220>
<223> Description of Artificial Sequence: Synthetic
      polypeptide

<400> 77
Ala Glu Asp Gln Asn Pro Tyr Trp Ala Arg Tyr Ala Asp Trp Leu Phe 
1               5                   10                  15      


Thr Thr Pro Leu Leu Leu Leu Glu Leu Ala Leu Leu Val Glu Cys Gly 
            20                  25                  30          


<210> 78
<211> 32
<212> PRT
<213> Artificial Sequence

<220>
<223> Description of Artificial Sequence: Synthetic
      polypeptide

<400> 78
Ala Lys Glu Asp Gln Asn Asp Pro Tyr Trp Ala Arg Tyr Ala Asp Trp 
1               5                   10                  15      


Leu Phe Thr Thr Pro Leu Leu Leu Leu Asp Leu Ala Leu Leu Val Gly 
            20                  25                  30          


<210> 79
<211> 30
<212> PRT
<213> Artificial Sequence

<220>
<223> Description of Artificial Sequence: Synthetic
      polypeptide

<400> 79
Ala Lys Glu Asp Gln Asn Pro Tyr Trp Arg Ala Tyr Ala Asp Leu Phe 
1               5                   10                  15      


Thr Pro Leu Thr Leu Leu Asp Leu Leu Ala Leu Trp Asp Gly 
            20                  25                  30  


<210> 80
<211> 31
<212> PRT
<213> Artificial Sequence

<220>
<223> Description of Artificial Sequence: Synthetic
      polypeptide

<400> 80
Ala Glu Asp Gln Asn Pro Tyr Trp Ala Arg Tyr Ala Asp Trp Leu Phe 
1               5                   10                  15      


Thr Thr Pro Leu Leu Leu Leu Glu Leu Ala Leu Leu Val Cys Gly 
            20                  25                  30      


<210> 81
<211> 30
<212> PRT
<213> Artificial Sequence

<220>
<223> Description of Artificial Sequence: Synthetic
      polypeptide

<400> 81
Ala Cys Glu Asp Gln Asn Pro Tyr Trp Arg Ala Tyr Ala Asp Leu Phe 
1               5                   10                  15      


Thr Pro Leu Thr Leu Leu Asp Leu Leu Ala Leu Trp Asp Gly 
            20                  25                  30  


<210> 82
<211> 27
<212> PRT
<213> Artificial Sequence

<220>
<223> Description of Artificial Sequence: Synthetic
      peptide

<400> 82
Ala Cys Asp Asp Gln Asn Pro Trp Arg Ala Tyr Leu Asp Leu Leu Phe 
1               5                   10                  15      


Pro Thr Asp Thr Leu Leu Leu Asp Leu Leu Trp 
            20                  25          


<210> 83
<211> 28
<212> PRT
<213> Artificial Sequence

<220>
<223> Description of Artificial Sequence: Synthetic
      peptide

<400> 83
Ala Lys Asp Asp Gln Asn Pro Trp Arg Ala Tyr Leu Asp Leu Leu Phe 
1               5                   10                  15      


Pro Thr Asp Thr Leu Leu Leu Asp Leu Leu Trp Cys 
            20                  25              


<210> 84
<211> 27
<212> PRT
<213> Artificial Sequence

<220>
<223> Description of Artificial Sequence: Synthetic
      peptide

<400> 84
Ala Cys Glu Glu Gln Asn Pro Trp Arg Ala Tyr Leu Glu Leu Leu Phe 
1               5                   10                  15      


Pro Thr Glu Thr Leu Leu Leu Glu Leu Leu Trp 
            20                  25          


<210> 85
<211> 25
<212> PRT
<213> Artificial Sequence

<220>
<223> Description of Artificial Sequence: Synthetic
      peptide

<400> 85
Ala Cys Asp Asp Gln Asn Pro Trp Ala Arg Tyr Leu Asp Trp Leu Phe 
1               5                   10                  15      


Pro Thr Asp Thr Leu Leu Leu Asp Leu 
            20                  25  


<210> 86
<211> 24
<212> PRT
<213> Artificial Sequence

<220>
<223> Description of Artificial Sequence: Synthetic
      peptide

<400> 86
Cys Asp Asn Asn Asn Pro Trp Arg Ala Tyr Leu Asp Leu Leu Phe Pro 
1               5                   10                  15      


Thr Asp Thr Leu Leu Leu Asp Trp 
            20                  


<210> 87
<211> 24
<212> PRT
<213> Artificial Sequence

<220>
<223> Description of Artificial Sequence: Synthetic
      peptide

<400> 87
Cys Glu Glu Gln Gln Pro Trp Ala Gln Tyr Leu Glu Leu Leu Phe Pro 
1               5                   10                  15      


Thr Glu Thr Leu Leu Leu Glu Trp 
            20                  


<210> 88
<211> 24
<212> PRT
<213> Artificial Sequence

<220>
<223> Description of Artificial Sequence: Synthetic
      peptide

<400> 88
Cys Glu Glu Gln Gln Pro Trp Arg Ala Tyr Leu Glu Leu Leu Phe Pro 
1               5                   10                  15      


Thr Glu Thr Leu Leu Leu Glu Trp 
            20                  


<210> 89
<211> 37
<212> PRT
<213> Artificial Sequence

<220>
<223> Description of Artificial Sequence: Synthetic
      polypeptide

<400> 89
Cys Asp Asp Asp Asp Asp Asn Pro Asn Tyr Trp Ala Arg Tyr Ala Asn 
1               5                   10                  15      


Trp Leu Phe Thr Thr Pro Leu Leu Leu Leu Asn Gly Ala Leu Leu Val 
            20                  25                  30          


Glu Ala Glu Glu Thr 
        35          


<210> 90
<211> 36
<212> PRT
<213> Artificial Sequence

<220>
<223> Description of Artificial Sequence: Synthetic
      polypeptide

<400> 90
Cys Asp Asp Asp Asp Asp Asn Pro Asn Tyr Trp Ala Arg Tyr Ala Pro 
1               5                   10                  15      


Trp Leu Phe Thr Thr Pro Leu Leu Leu Leu Pro Gly Ala Leu Leu Val 
            20                  25                  30          


Glu Ala Glu Glu 
        35      


<210> 91
<211> 34
<212> PRT
<213> Artificial Sequence

<220>
<223> Description of Artificial Sequence: Synthetic
      polypeptide

<400> 91
Thr Glu Asp Ala Asp Val Leu Leu Ala Leu Asp Leu Leu Leu Leu Pro 
1               5                   10                  15      


Thr Thr Phe Leu Trp Asp Ala Tyr Arg Ala Trp Tyr Pro Asn Gln Glu 
            20                  25                  30          


Cys Ala 
        


<210> 92
<211> 20
<212> PRT
<213> Artificial Sequence

<220>
<223> Description of Artificial Sequence: Synthetic
      peptide

<400> 92
Ala Glu Gln Asn Pro Ile Tyr Trp Ala Arg Tyr Ala Asp Trp Leu Phe 
1               5                   10                  15      


Thr Thr Pro Leu 
            20  


<210> 93
<211> 21
<212> PRT
<213> Artificial Sequence

<220>
<223> Description of Artificial Sequence: Synthetic
      peptide

<400> 93
Ala Glu Gln Asn Pro Ile Tyr Trp Ala Arg Tyr Ala Asp Trp Leu Phe 
1               5                   10                  15      


Thr Thr Pro Cys Leu 
            20      


<210> 94
<211> 21
<212> PRT
<213> Artificial Sequence

<220>
<223> Description of Artificial Sequence: Synthetic
      peptide

<400> 94
Ala Cys Glu Gln Asn Pro Ile Tyr Trp Ala Arg Tyr Ala Asp Trp Leu 
1               5                   10                  15      


Phe Thr Thr Pro Leu 
            20      


<210> 95
<211> 20
<212> PRT
<213> Artificial Sequence

<220>
<223> Description of Artificial Sequence: Synthetic
      peptide

<400> 95
Ala Glu Gln Asn Pro Ile Tyr Phe Ala Arg Tyr Ala Asp Trp Leu Phe 
1               5                   10                  15      


Thr Thr Pro Leu 
            20  


<210> 96
<211> 22
<212> PRT
<213> Artificial Sequence

<220>
<223> Description of Artificial Sequence: Synthetic
      peptide

<400> 96
Ala Glu Gln Asn Pro Ile Tyr Phe Ala Arg Tyr Ala Asp Leu Leu Phe 
1               5                   10                  15      


Pro Thr Thr Leu Ala Trp 
            20          


<210> 97
<211> 22
<212> PRT
<213> Artificial Sequence

<220>
<223> Description of Artificial Sequence: Synthetic
      peptide

<400> 97
Ala Glu Gln Asn Pro Ile Tyr Trp Ala Arg Tyr Ala Asp Leu Leu Phe 
1               5                   10                  15      


Pro Thr Thr Leu Ala Phe 
            20          


<210> 98
<211> 22
<212> PRT
<213> Artificial Sequence

<220>
<223> Description of Artificial Sequence: Synthetic
      peptide

<400> 98
Ala Glu Gln Asn Pro Ile Tyr Trp Ala Arg Tyr Ala Asp Leu Leu Phe 
1               5                   10                  15      


Pro Thr Thr Leu Ala Trp 
            20          


<210> 99
<211> 21
<212> PRT
<213> Artificial Sequence

<220>
<223> Description of Artificial Sequence: Synthetic
      peptide

<400> 99
Lys Glu Asp Gln Asn Pro Trp Ala Arg Tyr Ala Asp Leu Leu Phe Pro 
1               5                   10                  15      


Thr Thr Leu Ala Trp 
            20      


<210> 100
<211> 20
<212> PRT
<213> Artificial Sequence

<220>
<223> Description of Artificial Sequence: Synthetic
      peptide

<400> 100
Lys Glu Asp Gln Asn Pro Trp Ala Arg Tyr Ala Asp Leu Leu Phe Pro 
1               5                   10                  15      


Thr Thr Leu Trp 
            20  


<210> 101
<211> 22
<212> PRT
<213> Artificial Sequence

<220>
<223> Description of Artificial Sequence: Synthetic
      peptide

<400> 101
Ala Cys Glu Asp Gln Asn Pro Trp Ala Arg Tyr Ala Asp Leu Leu Phe 
1               5                   10                  15      


Pro Thr Thr Leu Ala Trp 
            20          


<210> 102
<211> 24
<212> PRT
<213> Artificial Sequence

<220>
<223> Description of Artificial Sequence: Synthetic
      peptide

<400> 102
Ala Cys Glu Asp Gln Asn Pro Trp Ala Arg Tyr Ala Asp Trp Leu Phe 
1               5                   10                  15      


Pro Thr Thr Leu Leu Leu Leu Asp 
            20                  


<210> 103
<211> 22
<212> PRT
<213> Artificial Sequence

<220>
<223> Description of Artificial Sequence: Synthetic
      peptide

<400> 103
Ala Cys Glu Glu Gln Asn Pro Trp Ala Arg Tyr Ala Glu Leu Leu Phe 
1               5                   10                  15      


Pro Thr Thr Leu Ala Trp 
            20          


<210> 104
<211> 24
<212> PRT
<213> Artificial Sequence

<220>
<223> Description of Artificial Sequence: Synthetic
      peptide

<400> 104
Ala Cys Glu Glu Gln Asn Pro Trp Ala Arg Tyr Ala Glu Trp Leu Phe 
1               5                   10                  15      


Pro Thr Thr Leu Leu Leu Leu Glu 
            20                  


<210> 105
<211> 25
<212> PRT
<213> Artificial Sequence

<220>
<223> Description of Artificial Sequence: Synthetic
      peptide

<400> 105
Ala Cys Glu Glu Gln Asn Pro Trp Ala Arg Tyr Leu Glu Trp Leu Phe 
1               5                   10                  15      


Pro Thr Glu Thr Leu Leu Leu Glu Leu 
            20                  25  


<210> 106
<211> 24
<212> PRT
<213> Artificial Sequence

<220>
<223> Description of Artificial Sequence: Synthetic
      peptide

<400> 106
Ala Cys Glu Glu Gln Asn Pro Gln Ala Glu Tyr Ala Glu Trp Leu Phe 
1               5                   10                  15      


Pro Thr Thr Leu Leu Leu Leu Glu 
            20                  


<210> 107
<211> 21
<212> PRT
<213> Artificial Sequence

<220>
<223> Description of Artificial Sequence: Synthetic
      peptide

<400> 107
Trp Ala Arg Tyr Ala Asp Trp Leu Phe Thr Thr Pro Leu Leu Leu Leu 
1               5                   10                  15      


Asp Leu Ala Leu Leu 
            20      


<210> 108
<211> 21
<212> PRT
<213> Artificial Sequence

<220>
<223> Description of Artificial Sequence: Synthetic
      peptide

<400> 108
Tyr Ala Arg Tyr Ala Asp Trp Leu Phe Thr Thr Pro Leu Leu Leu Leu 
1               5                   10                  15      


Asp Leu Ala Leu Leu 
            20      


<210> 109
<211> 21
<212> PRT
<213> Artificial Sequence

<220>
<223> Description of Artificial Sequence: Synthetic
      peptide

<400> 109
Trp Ala Arg Tyr Ser Asp Trp Leu Phe Thr Thr Pro Leu Leu Leu Tyr 
1               5                   10                  15      


Asp Leu Gly Leu Leu 
            20      


<210> 110
<211> 21
<212> PRT
<213> Artificial Sequence

<220>
<223> Description of Artificial Sequence: Synthetic
      peptide

<400> 110
Trp Ala Arg Tyr Thr Asp Trp Phe Thr Thr Pro Leu Leu Leu Tyr Asp 
1               5                   10                  15      


Leu Ala Leu Leu Ala 
            20      


<210> 111
<211> 21
<212> PRT
<213> Artificial Sequence

<220>
<223> Description of Artificial Sequence: Synthetic
      peptide

<400> 111
Trp Ala Arg Tyr Thr Asp Trp Leu Phe Thr Thr Pro Leu Leu Leu Tyr 
1               5                   10                  15      


Asp Leu Gly Leu Leu 
            20      


<210> 112
<211> 21
<212> PRT
<213> Artificial Sequence

<220>
<223> Description of Artificial Sequence: Synthetic
      peptide

<400> 112
Trp Ala Arg Tyr Ala Asp Trp Leu Phe Thr Thr Pro Leu Leu Leu Leu 
1               5                   10                  15      


Asp Leu Ser Leu Leu 
            20      


<210> 113
<211> 21
<212> PRT
<213> Artificial Sequence

<220>
<223> Description of Artificial Sequence: Synthetic
      peptide

<400> 113
Leu Leu Ala Leu Asp Leu Leu Leu Leu Pro Thr Thr Phe Leu Trp Asp 
1               5                   10                  15      


Ala Tyr Arg Ala Trp 
            20      


<210> 114
<211> 21
<212> PRT
<213> Artificial Sequence

<220>
<223> Description of Artificial Sequence: Synthetic
      peptide

<400> 114
Leu Leu Ala Leu Asp Leu Leu Leu Leu Pro Thr Thr Phe Leu Trp Asp 
1               5                   10                  15      


Ala Tyr Arg Ala Tyr 
            20      


<210> 115
<211> 21
<212> PRT
<213> Artificial Sequence

<220>
<223> Description of Artificial Sequence: Synthetic
      peptide

<400> 115
Leu Leu Gly Leu Asp Tyr Leu Leu Leu Pro Thr Thr Phe Leu Trp Asp 
1               5                   10                  15      


Ser Tyr Arg Ala Trp 
            20      


<210> 116
<211> 21
<212> PRT
<213> Artificial Sequence

<220>
<223> Description of Artificial Sequence: Synthetic
      peptide

<400> 116
Ala Leu Leu Ala Leu Asp Tyr Leu Leu Leu Pro Thr Thr Phe Trp Asp 
1               5                   10                  15      


Thr Tyr Arg Ala Trp 
            20      


<210> 117
<211> 21
<212> PRT
<213> Artificial Sequence

<220>
<223> Description of Artificial Sequence: Synthetic
      peptide

<400> 117
Leu Leu Gly Leu Asp Tyr Leu Leu Leu Pro Thr Thr Phe Leu Trp Asp 
1               5                   10                  15      


Thr Tyr Arg Ala Trp 
            20      


<210> 118
<211> 21
<212> PRT
<213> Artificial Sequence

<220>
<223> Description of Artificial Sequence: Synthetic
      peptide

<400> 118
Leu Leu Ser Leu Asp Leu Leu Leu Leu Pro Thr Thr Phe Leu Trp Asp 
1               5                   10                  15      


Ala Tyr Arg Ala Trp 
            20      


<210> 119
<211> 26
<212> PRT
<213> Artificial Sequence

<220>
<223> Description of Artificial Sequence: Synthetic
      peptide

<400> 119
Gly Leu Ala Gly Leu Leu Gly Leu Glu Gly Leu Leu Gly Leu Pro Leu 
1               5                   10                  15      


Gly Leu Leu Glu Gly Leu Trp Leu Gly Leu 
            20                  25      


<210> 120
<211> 26
<212> PRT
<213> Artificial Sequence

<220>
<223> Description of Artificial Sequence: Synthetic
      peptide

<400> 120
Leu Gly Leu Trp Leu Gly Glu Leu Leu Gly Leu Pro Leu Gly Leu Leu 
1               5                   10                  15      


Gly Glu Leu Gly Leu Leu Gly Ala Leu Gly 
            20                  25      


<210> 121
<211> 20
<212> PRT
<213> Artificial Sequence

<220>
<223> Description of Artificial Sequence: Synthetic
      peptide

<400> 121
Trp Arg Ala Tyr Leu Asp Leu Leu Phe Pro Thr Asp Thr Leu Leu Leu 
1               5                   10                  15      


Asp Leu Leu Trp 
            20  


<210> 122
<211> 20
<212> PRT
<213> Artificial Sequence

<220>
<223> Description of Artificial Sequence: Synthetic
      peptide

<400> 122
Trp Leu Leu Asp Leu Leu Leu Thr Asp Thr Pro Phe Leu Leu Asp Leu 
1               5                   10                  15      


Tyr Ala Arg Trp 
            20  


<210> 123
<211> 18
<212> PRT
<213> Artificial Sequence

<220>
<223> Description of Artificial Sequence: Synthetic
      peptide

<400> 123
Trp Ala Arg Tyr Leu Glu Trp Leu Phe Pro Thr Glu Thr Leu Leu Leu 
1               5                   10                  15      


Glu Leu 
        


<210> 124
<211> 18
<212> PRT
<213> Artificial Sequence

<220>
<223> Description of Artificial Sequence: Synthetic
      peptide

<400> 124
Trp Ala Gln Tyr Leu Glu Leu Leu Phe Pro Thr Glu Thr Leu Leu Leu 
1               5                   10                  15      


Glu Trp 
        


<210> 125
<211> 18
<212> PRT
<213> Artificial Sequence

<220>
<223> Description of Artificial Sequence: Synthetic
      peptide

<400> 125
Leu Glu Leu Leu Leu Thr Glu Thr Pro Phe Leu Trp Glu Leu Tyr Arg 
1               5                   10                  15      


Ala Trp 
        


<210> 126
<211> 18
<212> PRT
<213> Artificial Sequence

<220>
<223> Description of Artificial Sequence: Synthetic
      peptide

<400> 126
Trp Glu Leu Leu Leu Thr Glu Thr Pro Phe Leu Leu Glu Leu Tyr Gln 
1               5                   10                  15      


Ala Trp 
        


<210> 127
<211> 17
<212> PRT
<213> Artificial Sequence

<220>
<223> Description of Artificial Sequence: Synthetic
      peptide

<400> 127
Trp Leu Phe Thr Thr Pro Leu Leu Leu Leu Asn Gly Ala Leu Leu Val 
1               5                   10                  15      


Glu 
    


<210> 128
<211> 17
<212> PRT
<213> Artificial Sequence

<220>
<223> Description of Artificial Sequence: Synthetic
      peptide

<400> 128
Trp Leu Phe Thr Thr Pro Leu Leu Leu Leu Pro Gly Ala Leu Leu Val 
1               5                   10                  15      


Glu 
    


<210> 129
<211> 15
<212> PRT
<213> Artificial Sequence

<220>
<223> Description of Artificial Sequence: Synthetic
      peptide

<400> 129
Trp Ala Arg Tyr Ala Asp Leu Leu Phe Pro Thr Thr Leu Ala Trp 
1               5                   10                  15  


<210> 130
<211> 17
<212> PRT
<213> Artificial Sequence

<220>
<223> Description of Artificial Sequence: Synthetic
      peptide

<400> 130
Glu Val Leu Leu Ala Gly Asn Leu Leu Leu Leu Pro Thr Thr Phe Leu 
1               5                   10                  15      


Trp 
    


<210> 131
<211> 17
<212> PRT
<213> Artificial Sequence

<220>
<223> Description of Artificial Sequence: Synthetic
      peptide

<400> 131
Glu Val Leu Leu Ala Gly Pro Leu Leu Leu Leu Pro Thr Thr Phe Leu 
1               5                   10                  15      


Trp 
    


<210> 132
<211> 15
<212> PRT
<213> Artificial Sequence

<220>
<223> Description of Artificial Sequence: Synthetic
      peptide

<400> 132
Trp Ala Leu Thr Thr Pro Phe Leu Leu Asp Ala Tyr Arg Ala Trp 
1               5                   10                  15  


<210> 133
<211> 24
<212> PRT
<213> Artificial Sequence

<220>
<223> Description of Artificial Sequence: Synthetic
      peptide

<400> 133
Asn Leu Glu Gly Phe Phe Ala Thr Leu Gly Gly Glu Ile Ala Leu Trp 
1               5                   10                  15      


Ser Leu Val Val Leu Ala Ile Glu 
            20                  


<210> 134
<211> 22
<212> PRT
<213> Artificial Sequence

<220>
<223> Description of Artificial Sequence: Synthetic
      peptide

<400> 134
Glu Gly Phe Phe Ala Thr Leu Gly Gly Glu Ile Ala Leu Trp Ser Asp 
1               5                   10                  15      


Val Val Leu Ala Ile Glu 
            20          


<210> 135
<211> 22
<212> PRT
<213> Artificial Sequence

<220>
<223> Description of Artificial Sequence: Synthetic
      peptide

<400> 135
Glu Gly Phe Phe Ala Thr Leu Gly Gly Glu Ile Pro Leu Trp Ser Asp 
1               5                   10                  15      


Val Val Leu Ala Ile Glu 
            20          


<210> 136
<211> 24
<212> PRT
<213> Artificial Sequence

<220>
<223> Description of Artificial Sequence: Synthetic
      peptide

<400> 136
Glu Ile Ala Leu Val Val Leu Ser Trp Leu Ala Ile Glu Gly Gly Leu 
1               5                   10                  15      


Thr Ala Phe Phe Gly Glu Leu Asn 
            20                  


<210> 137
<211> 22
<212> PRT
<213> Artificial Sequence

<220>
<223> Description of Artificial Sequence: Synthetic
      peptide

<400> 137
Glu Ile Ala Leu Val Val Asp Ser Trp Leu Ala Ile Glu Gly Gly Leu 
1               5                   10                  15      


Thr Ala Phe Phe Gly Glu 
            20          


<210> 138
<211> 22
<212> PRT
<213> Artificial Sequence

<220>
<223> Description of Artificial Sequence: Synthetic
      peptide

<400> 138
Glu Ile Ala Leu Val Val Asp Ser Trp Leu Pro Ile Glu Gly Gly Leu 
1               5                   10                  15      


Thr Ala Phe Phe Gly Glu 
            20          


<210> 139
<211> 21
<212> PRT
<213> Artificial Sequence

<220>
<223> Description of Artificial Sequence: Synthetic
      peptide

<400> 139
Ile Leu Asp Leu Val Phe Gly Leu Leu Phe Ala Val Thr Ser Val Asp 
1               5                   10                  15      


Phe Leu Val Gln Trp 
            20      


<210> 140
<211> 21
<212> PRT
<213> Artificial Sequence

<220>
<223> Description of Artificial Sequence: Synthetic
      peptide

<400> 140
Trp Gln Val Leu Phe Asp Val Ser Thr Val Ala Phe Leu Leu Gly Phe 
1               5                   10                  15      


Val Leu Asp Leu Ile 
            20      


<210> 141
<211> 34
<212> PRT
<213> Artificial Sequence

<220>
<223> Description of Artificial Sequence: Synthetic
      polypeptide

<400> 141
Ala Glu Gln Asn Pro Ile Tyr Trp Ala Arg Tyr Ala Asp Trp Leu Phe 
1               5                   10                  15      


Thr Thr Pro Leu Leu Leu Leu Asp Leu Ala Leu Leu Val Asp Ala Asp 
            20                  25                  30          


Glu Thr 
        


<210> 142
<211> 34
<212> PRT
<213> Artificial Sequence

<220>
<223> Description of Artificial Sequence: Synthetic
      polypeptide

<400> 142
Ala Glu Gln Asn Pro Ile Tyr Trp Ala Arg Tyr Ala Glu Trp Leu Phe 
1               5                   10                  15      


Thr Thr Pro Leu Leu Leu Leu Glu Leu Ala Leu Leu Val Glu Ala Glu 
            20                  25                  30          


Glu Thr 
        


<210> 143
<211> 33
<212> PRT
<213> Artificial Sequence

<220>
<223> Description of Artificial Sequence: Synthetic
      polypeptide

<400> 143
Ala Asp Asp Gln Asn Pro Trp Arg Ala Tyr Leu Asp Leu Leu Phe Pro 
1               5                   10                  15      


Asp Thr Thr Asp Leu Leu Leu Leu Asp Leu Leu Trp Asp Ala Asp Glu 
            20                  25                  30          


Thr 
    


<210> 144
<211> 33
<212> PRT
<213> Artificial Sequence

<220>
<223> Description of Artificial Sequence: Synthetic
      polypeptide

<400> 144
Ala Glu Glu Gln Asn Pro Trp Arg Ala Tyr Leu Glu Leu Leu Phe Pro 
1               5                   10                  15      


Glu Thr Thr Glu Leu Leu Leu Leu Glu Leu Leu Trp Glu Ala Glu Glu 
            20                  25                  30          


Thr 
    


<210> 145
<211> 34
<212> PRT
<213> Artificial Sequence

<220>
<223> Description of Artificial Sequence: Synthetic
      polypeptide


<220>
<221> MOD_RES
<222> (13)..(13)
<223> Gamma-carboxyglutamic acid

<400> 145
Ala Glu Gln Asn Pro Ile Tyr Trp Ala Arg Tyr Ala Xaa Trp Leu Phe 
1               5                   10                  15      


Thr Thr Pro Leu Leu Leu Leu Asp Leu Ala Leu Leu Val Asp Ala Asp 
            20                  25                  30          


Glu Thr 
        


<210> 146
<211> 34
<212> PRT
<213> Artificial Sequence

<220>
<223> Description of Artificial Sequence: Synthetic
      polypeptide


<220>
<221> MOD_RES
<222> (24)..(24)
<223> Gamma-carboxyglutamic acid

<400> 146
Ala Glu Gln Asn Pro Ile Tyr Trp Ala Arg Tyr Ala Asp Trp Leu Phe 
1               5                   10                  15      


Thr Thr Pro Leu Leu Leu Leu Xaa Leu Ala Leu Leu Val Asp Ala Asp 
            20                  25                  30          


Glu Thr 
        


<210> 147
<211> 34
<212> PRT
<213> Artificial Sequence

<220>
<223> Description of Artificial Sequence: Synthetic
      polypeptide


<220>
<221> MOD_RES
<222> (13)..(13)
<223> Gamma-carboxyglutamic acid

<220>
<221> MOD_RES
<222> (24)..(24)
<223> Gamma-carboxyglutamic acid

<400> 147
Ala Glu Gln Asn Pro Ile Tyr Trp Ala Arg Tyr Ala Xaa Trp Leu Phe 
1               5                   10                  15      


Thr Thr Pro Leu Leu Leu Leu Xaa Leu Ala Leu Leu Val Asp Ala Asp 
            20                  25                  30          


Glu Thr 
        


<210> 148
<211> 34
<212> PRT
<213> Artificial Sequence

<220>
<223> Description of Artificial Sequence: Synthetic
      polypeptide


<220>
<221> MOD_RES
<222> (13)..(13)
<223> Alpha-aminoadipic acid

<400> 148
Ala Glu Gln Asn Pro Ile Tyr Trp Ala Arg Tyr Ala Xaa Trp Leu Phe 
1               5                   10                  15      


Thr Thr Pro Leu Leu Leu Leu Asp Leu Ala Leu Leu Val Asp Ala Asp 
            20                  25                  30          


Glu Thr 
        


<210> 149
<211> 34
<212> PRT
<213> Artificial Sequence

<220>
<223> Description of Artificial Sequence: Synthetic
      polypeptide


<220>
<221> MOD_RES
<222> (24)..(24)
<223> Alpha-aminoadipic acid

<400> 149
Ala Glu Gln Asn Pro Ile Tyr Trp Ala Arg Tyr Ala Asp Trp Leu Phe 
1               5                   10                  15      


Thr Thr Pro Leu Leu Leu Leu Xaa Leu Ala Leu Leu Val Asp Ala Asp 
            20                  25                  30          


Glu Thr 
        


<210> 150
<211> 34
<212> PRT
<213> Artificial Sequence

<220>
<223> Description of Artificial Sequence: Synthetic
      polypeptide


<220>
<221> MOD_RES
<222> (13)..(13)
<223> Alpha-aminoadipic acid

<220>
<221> MOD_RES
<222> (24)..(24)
<223> Alpha-aminoadipic acid

<400> 150
Ala Glu Gln Asn Pro Ile Tyr Trp Ala Arg Tyr Ala Xaa Trp Leu Phe 
1               5                   10                  15      


Thr Thr Pro Leu Leu Leu Leu Xaa Leu Ala Leu Leu Val Asp Ala Asp 
            20                  25                  30          


Glu Thr 
        


<210> 151
<211> 34
<212> PRT
<213> Artificial Sequence

<220>
<223> Description of Artificial Sequence: Synthetic
      polypeptide


<220>
<221> MOD_RES
<222> (13)..(13)
<223> Gamma-carboxyglutamic acid

<220>
<221> MOD_RES
<222> (24)..(24)
<223> Alpha-aminoadipic acid

<400> 151
Ala Glu Gln Asn Pro Ile Tyr Trp Ala Arg Tyr Ala Xaa Trp Leu Phe 
1               5                   10                  15      


Thr Thr Pro Leu Leu Leu Leu Xaa Leu Ala Leu Leu Val Asp Ala Asp 
            20                  25                  30          


Glu Thr 
        


<210> 152
<211> 34
<212> PRT
<213> Artificial Sequence

<220>
<223> Description of Artificial Sequence: Synthetic
      polypeptide


<220>
<221> MOD_RES
<222> (13)..(13)
<223> Alpha-aminoadipic acid

<220>
<221> MOD_RES
<222> (24)..(24)
<223> Gamma-carboxyglutamic acid

<400> 152
Ala Glu Gln Asn Pro Ile Tyr Trp Ala Arg Tyr Ala Xaa Trp Leu Phe 
1               5                   10                  15      


Thr Thr Pro Leu Leu Leu Leu Xaa Leu Ala Leu Leu Val Asp Ala Asp 
            20                  25                  30          


Glu Thr 
        


<210> 153
<211> 36
<212> PRT
<213> Artificial Sequence

<220>
<223> Description of Artificial Sequence: Synthetic
      polypeptide

<400> 153
Gly Gly Glu Gln Asn Pro Ile Tyr Trp Ala Arg Tyr Ala Asp Trp Leu 
1               5                   10                  15      


Phe Thr Thr Pro Leu Leu Leu Leu Asp Leu Ala Leu Leu Val Asp Ala 
            20                  25                  30          


Asp Glu Gly Thr 
        35      


<210> 154
<211> 36
<212> PRT
<213> Artificial Sequence

<220>
<223> Description of Artificial Sequence: Synthetic
      polypeptide

<400> 154
Gly Gly Glu Gln Asn Pro Ile Tyr Trp Ala Arg Tyr Ala Asp Trp Leu 
1               5                   10                  15      


Phe Thr Thr Pro Leu Leu Leu Leu Asp Leu Ala Leu Leu Val Asp Ala 
            20                  25                  30          


Asp Glu Gly Thr 
        35      


<210> 155
<211> 36
<212> PRT
<213> Artificial Sequence

<220>
<223> Description of Artificial Sequence: Synthetic
      polypeptide

<400> 155
Ala Ala Glu Gln Asn Pro Ile Tyr Trp Ala Arg Tyr Ala Asp Trp Leu 
1               5                   10                  15      


Phe Thr Thr Pro Leu Leu Leu Leu Asp Leu Ala Leu Leu Val Asp Ala 
            20                  25                  30          


Asp Glu Gly Thr 
        35      


<210> 156
<211> 35
<212> PRT
<213> Artificial Sequence

<220>
<223> Description of Artificial Sequence: Synthetic
      polypeptide

<400> 156
Ala Glu Gln Asn Pro Ile Tyr Trp Ala Arg Tyr Ala Asp Trp Leu Phe 
1               5                   10                  15      


Thr Thr Pro Leu Leu Leu Leu Asp Leu Ala Leu Leu Val Asp Ala Asp 
            20                  25                  30          


Glu Gly Thr 
        35  


<210> 157
<211> 35
<212> PRT
<213> Artificial Sequence

<220>
<223> Description of Artificial Sequence: Synthetic
      polypeptide

<400> 157
Ala Glu Gln Asn Pro Ile Tyr Trp Ala Arg Tyr Ala Asn Trp Leu Phe 
1               5                   10                  15      


Thr Thr Pro Leu Leu Leu Leu Asn Leu Ala Leu Leu Val Asp Ala Asp 
            20                  25                  30          


Glu Gly Thr 
        35  


<210> 158
<211> 35
<212> PRT
<213> Artificial Sequence

<220>
<223> Description of Artificial Sequence: Synthetic
      polypeptide

<400> 158
Ala Glu Gln Asn Pro Ile Tyr Trp Ala Arg Tyr Ala Lys Trp Leu Phe 
1               5                   10                  15      


Thr Thr Pro Leu Leu Leu Leu Lys Leu Ala Leu Leu Val Asp Ala Asp 
            20                  25                  30          


Glu Gly Thr 
        35  


<210> 159
<211> 36
<212> PRT
<213> Artificial Sequence

<220>
<223> Description of Artificial Sequence: Synthetic
      polypeptide

<400> 159
Gly Gly Glu Gln Asn Pro Ile Tyr Trp Ala Arg Tyr Ala Asp Trp Leu 
1               5                   10                  15      


Phe Thr Thr Pro Leu Leu Leu Leu Asp Leu Ala Leu Leu Val Asn Ala 
            20                  25                  30          


Asn Gln Gly Thr 
        35      


<210> 160
<211> 36
<212> PRT
<213> Artificial Sequence

<220>
<223> Description of Artificial Sequence: Synthetic
      polypeptide

<400> 160
Ala Ala Glu Gln Asn Pro Ile Tyr Trp Ala Arg Tyr Ala Asp Trp Leu 
1               5                   10                  15      


Phe Thr Thr Pro Leu Leu Leu Leu Ala Leu Ala Leu Leu Val Asp Ala 
            20                  25                  30          


Asp Glu Gly Thr 
        35      


<210> 161
<211> 36
<212> PRT
<213> Artificial Sequence

<220>
<223> Description of Artificial Sequence: Synthetic
      polypeptide

<400> 161
Ala Ala Glu Gln Asn Pro Ile Tyr Trp Ala Arg Tyr Ala Ala Trp Leu 
1               5                   10                  15      


Phe Thr Thr Pro Leu Leu Leu Leu Asp Leu Ala Leu Leu Val Asp Ala 
            20                  25                  30          


Asp Glu Gly Thr 
        35      


<210> 162
<211> 36
<212> PRT
<213> Artificial Sequence

<220>
<223> Description of Artificial Sequence: Synthetic
      polypeptide

<400> 162
Ala Ala Glu Gln Asn Pro Ile Tyr Trp Ala Arg Tyr Ala Asp Trp Leu 
1               5                   10                  15      


Phe Thr Thr Ala Leu Leu Leu Leu Asp Leu Ala Leu Leu Val Asp Ala 
            20                  25                  30          


Asp Glu Gly Thr 
        35      


<210> 163
<211> 36
<212> PRT
<213> Artificial Sequence

<220>
<223> Description of Artificial Sequence: Synthetic
      polypeptide

<400> 163
Ala Ala Glu Gln Asn Pro Ile Tyr Trp Ala Arg Tyr Ala Asp Trp Leu 
1               5                   10                  15      


Phe Thr Thr Pro Leu Leu Leu Leu Glu Leu Ala Leu Leu Val Asp Ala 
            20                  25                  30          


Asp Glu Gly Thr 
        35      


<210> 164
<211> 36
<212> PRT
<213> Artificial Sequence

<220>
<223> Description of Artificial Sequence: Synthetic
      polypeptide

<400> 164
Ala Ala Glu Gln Asn Pro Ile Tyr Trp Ala Arg Tyr Ala Glu Trp Leu 
1               5                   10                  15      


Phe Thr Thr Pro Leu Leu Leu Leu Asp Leu Ala Leu Leu Val Asp Ala 
            20                  25                  30          


Asp Glu Gly Thr 
        35      


<210> 165
<211> 39
<212> PRT
<213> Artificial Sequence

<220>
<223> Description of Artificial Sequence: Synthetic
      polypeptide

<400> 165
Ala Ala Glu Gln Asn Pro Ile Ile Tyr Trp Ala Arg Tyr Ala Asp Trp 
1               5                   10                  15      


Leu Phe Thr Asp Leu Pro Leu Leu Leu Leu Asp Leu Leu Ala Leu Leu 
            20                  25                  30          


Val Asp Ala Asp Glu Gly Thr 
        35                  


<210> 166
<211> 34
<212> PRT
<213> Artificial Sequence

<220>
<223> Description of Artificial Sequence: Synthetic
      polypeptide

<400> 166
Gly Glu Gln Asn Pro Ile Tyr Trp Ala Gln Tyr Ala Asp Trp Leu Phe 
1               5                   10                  15      


Thr Thr Pro Leu Leu Leu Leu Asp Leu Ala Leu Leu Val Asp Ala Asp 
            20                  25                  30          


Glu Gly 
        


<210> 167
<211> 35
<212> PRT
<213> Artificial Sequence

<220>
<223> Description of Artificial Sequence: Synthetic
      polypeptide

<400> 167
Gly Gly Glu Gln Asn Pro Ile Tyr Trp Ala Arg Tyr Ala Asp Trp Leu 
1               5                   10                  15      


Phe Thr Thr Pro Leu Leu Leu Asp Leu Leu Ala Leu Leu Val Asp Ala 
            20                  25                  30          


Asp Glu Gly 
        35  


<210> 168

<400> 168
000


<210> 169
<211> 35
<212> PRT
<213> Artificial Sequence

<220>
<223> Description of Artificial Sequence: Synthetic
      polypeptide

<400> 169
Gly Gly Glu Gln Asn Pro Ile Tyr Trp Ala Arg Tyr Ala Asp Trp Leu 
1               5                   10                  15      


Phe Thr Thr Pro Leu Leu Leu Leu Leu Asp Ala Leu Leu Val Asp Ala 
            20                  25                  30          


Asp Glu Gly 
        35  


<210> 170
<211> 36
<212> PRT
<213> Artificial Sequence

<220>
<223> Description of Artificial Sequence: Synthetic
      polypeptide

<400> 170
Gly Gly Glu Gln Asn Pro Ile Tyr Trp Ala Arg Tyr Asp Ala Trp Leu 
1               5                   10                  15      


Phe Thr Thr Pro Leu Leu Leu Leu Asp Leu Ala Leu Leu Val Asp Ala 
            20                  25                  30          


Asp Glu Gly Thr 
        35      


<210> 171
<211> 35
<212> PRT
<213> Artificial Sequence

<220>
<223> Description of Artificial Sequence: Synthetic
      polypeptide

<400> 171
Gly Gly Glu Gln Asn Pro Ile Tyr Trp Ala Arg Tyr Ala Trp Asp Leu 
1               5                   10                  15      


Phe Thr Thr Pro Leu Leu Leu Leu Asp Leu Ala Leu Leu Val Asp Ala 
            20                  25                  30          


Asp Glu Gly 
        35  


<210> 172
<211> 36
<212> PRT
<213> Artificial Sequence

<220>
<223> Description of Artificial Sequence: Synthetic
      polypeptide

<400> 172
Ala Ala Glu Gln Asn Pro Ile Tyr Trp Ala Arg Tyr Ala Asp Trp Leu 
1               5                   10                  15      


Phe Thr Thr Gly Leu Leu Leu Leu Asp Leu Ala Leu Leu Val Asp Ala 
            20                  25                  30          


Asp Glu Gly Thr 
        35      


<210> 173
<211> 34
<212> PRT
<213> Artificial Sequence

<220>
<223> Description of Artificial Sequence: Synthetic
      polypeptide

<400> 173
Asp Asp Asp Glu Asp Asn Pro Ile Tyr Trp Ala Arg Tyr Ala Asp Trp 
1               5                   10                  15      


Leu Phe Thr Thr Pro Leu Leu Leu Leu His Gly Ala Leu Leu Val Asp 
            20                  25                  30          


Ala Asp 
        


<210> 174
<211> 35
<212> PRT
<213> Artificial Sequence

<220>
<223> Description of Artificial Sequence: Synthetic
      polypeptide

<400> 174
Asp Asp Asp Glu Asp Asn Pro Ile Tyr Trp Ala Arg Tyr Ala His Trp 
1               5                   10                  15      


Leu Phe Thr Thr Pro Leu Leu Leu Leu His Gly Ala Leu Leu Val Asp 
            20                  25                  30          


Ala Asp Glu 
        35  


<210> 175
<211> 33
<212> PRT
<213> Artificial Sequence

<220>
<223> Description of Artificial Sequence: Synthetic
      polypeptide

<400> 175
Cys Glu Gln Asn Pro Ile Tyr Trp Ala Arg Tyr Ala Asp Trp His Phe 
1               5                   10                  15      


Thr Thr Pro Leu Leu Leu Leu Asp Leu Ala Leu Leu Val Asp Ala Asp 
            20                  25                  30          


Glu 
    


<210> 176
<211> 34
<212> PRT
<213> Artificial Sequence

<220>
<223> Description of Artificial Sequence: Synthetic
      polypeptide

<400> 176
Ala Glu Gln Asn Pro Ile Tyr Trp Ala Arg Tyr Ala Asp Phe Leu Phe 
1               5                   10                  15      


Thr Thr Pro Leu Leu Leu Leu Asp Leu Ala Leu Leu Val Asp Ala Asp 
            20                  25                  30          


Glu Thr 
        


<210> 177
<211> 33
<212> PRT
<213> Artificial Sequence

<220>
<223> Description of Artificial Sequence: Synthetic
      polypeptide

<400> 177
Ala Glu Gln Asn Pro Ile Tyr Phe Ala Arg Tyr Ala Asp Trp Leu Phe 
1               5                   10                  15      


Thr Thr Pro Leu Leu Leu Leu Asp Leu Ala Leu Leu Val Asp Ala Asp 
            20                  25                  30          


Glu 
    


<210> 178
<211> 34
<212> PRT
<213> Artificial Sequence

<220>
<223> Description of Artificial Sequence: Synthetic
      polypeptide

<400> 178
Ala Glu Gln Asn Pro Ile Tyr Phe Ala Arg Tyr Ala Asp Phe Leu Phe 
1               5                   10                  15      


Thr Thr Pro Leu Leu Leu Leu Asp Leu Ala Leu Leu Trp Asp Ala Asp 
            20                  25                  30          


Glu Thr 
        


<210> 179
<211> 32
<212> PRT
<213> Artificial Sequence

<220>
<223> Description of Artificial Sequence: Synthetic
      polypeptide

<400> 179
Ala Asp Asn Asn Pro Trp Ile Tyr Ala Arg Tyr Ala Asp Leu Thr Thr 
1               5                   10                  15      


Phe Pro Leu Leu Leu Leu Asp Leu Ala Leu Leu Val Asp Phe Asp Asp 
            20                  25                  30          


<210> 180
<211> 32
<212> PRT
<213> Artificial Sequence

<220>
<223> Description of Artificial Sequence: Synthetic
      polypeptide

<400> 180
Ala Asp Asn Asn Pro Phe Ile Tyr Ala Arg Tyr Ala Asp Leu Thr Thr 
1               5                   10                  15      


Trp Pro Leu Leu Leu Leu Asp Leu Ala Leu Leu Val Asp Phe Asp Asp 
            20                  25                  30          


<210> 181
<211> 32
<212> PRT
<213> Artificial Sequence

<220>
<223> Description of Artificial Sequence: Synthetic
      polypeptide

<400> 181
Ala Asp Asn Asn Pro Phe Ile Tyr Ala Arg Tyr Ala Asp Leu Thr Thr 
1               5                   10                  15      


Phe Pro Leu Leu Leu Leu Asp Leu Ala Leu Leu Val Asp Trp Asp Asp 
            20                  25                  30          


<210> 182
<211> 32
<212> PRT
<213> Artificial Sequence

<220>
<223> Description of Artificial Sequence: Synthetic
      polypeptide

<400> 182
Ala Asp Asn Asn Pro Phe Pro Tyr Ala Arg Tyr Ala Asp Leu Thr Thr 
1               5                   10                  15      


Trp Ile Leu Leu Leu Leu Asp Leu Ala Leu Leu Val Asp Phe Asp Asp 
            20                  25                  30          


<210> 183
<211> 32
<212> PRT
<213> Artificial Sequence

<220>
<223> Description of Artificial Sequence: Synthetic
      polypeptide

<400> 183
Ala Asp Asn Asn Pro Phe Ile Tyr Ala Tyr Arg Ala Asp Leu Thr Thr 
1               5                   10                  15      


Phe Pro Leu Leu Leu Leu Asp Leu Ala Leu Leu Val Asp Trp Asp Asp 
            20                  25                  30          


<210> 184
<211> 32
<212> PRT
<213> Artificial Sequence

<220>
<223> Description of Artificial Sequence: Synthetic
      polypeptide

<400> 184
Ala Asp Asn Asn Pro Phe Ile Tyr Ala Thr Tyr Ala Asp Leu Arg Thr 
1               5                   10                  15      


Phe Pro Leu Leu Leu Leu Asp Leu Ala Leu Leu Val Asp Trp Asp Asp 
            20                  25                  30          


<210> 185
<211> 33
<212> PRT
<213> Artificial Sequence

<220>
<223> Description of Artificial Sequence: Synthetic
      polypeptide

<400> 185
Thr Glu Asp Ala Asp Val Leu Leu Ala Leu Asp Leu Leu Leu Leu Pro 
1               5                   10                  15      


Thr Thr Phe Leu Trp Asp Ala Tyr Arg Ala Trp Tyr Pro Asn Gln Glu 
            20                  25                  30          


Ala 
    


<210> 186
<211> 30
<212> PRT
<213> Artificial Sequence

<220>
<223> Description of Artificial Sequence: Synthetic
      polypeptide

<400> 186
Ala Glu Asp Gln Asn Pro Tyr Trp Ala Arg Tyr Ala Asp Trp Leu Phe 
1               5                   10                  15      


Thr Thr Pro Leu Leu Leu Leu Asp Leu Ala Leu Leu Val Asp 
            20                  25                  30  


<210> 187
<211> 30
<212> PRT
<213> Artificial Sequence

<220>
<223> Description of Artificial Sequence: Synthetic
      polypeptide

<400> 187
Ala Glu Asp Gln Asn Pro Tyr Trp Ala Arg Tyr Ala Asp Trp Leu Phe 
1               5                   10                  15      


Thr Thr Pro Leu Leu Leu Leu Glu Leu Ala Leu Leu Val Glu 
            20                  25                  30  


<210> 188
<211> 28
<212> PRT
<213> Artificial Sequence

<220>
<223> Description of Artificial Sequence: Synthetic
      peptide

<400> 188
Ala Glu Asp Gln Asn Pro Tyr Trp Arg Ala Tyr Ala Asp Leu Phe Thr 
1               5                   10                  15      


Pro Leu Thr Leu Leu Asp Leu Leu Ala Leu Trp Asp 
            20                  25              


<210> 189
<211> 26
<212> PRT
<213> Artificial Sequence

<220>
<223> Description of Artificial Sequence: Synthetic
      peptide

<400> 189
Ala Asp Asp Gln Asn Pro Trp Arg Ala Tyr Leu Asp Leu Leu Phe Pro 
1               5                   10                  15      


Thr Asp Thr Leu Leu Leu Asp Leu Leu Trp 
            20                  25      


<210> 190
<211> 30
<212> PRT
<213> Artificial Sequence

<220>
<223> Description of Artificial Sequence: Synthetic
      polypeptide

<400> 190
Ala Asp Asp Gln Asn Pro Trp Arg Ala Tyr Leu Asp Leu Leu Phe Pro 
1               5                   10                  15      


Thr Asp Thr Leu Leu Leu Asp Leu Leu Trp Asp Ala Asp Glu 
            20                  25                  30  


<210> 191
<211> 26
<212> PRT
<213> Artificial Sequence

<220>
<223> Description of Artificial Sequence: Synthetic
      peptide


<220>
<221> MOD_RES
<222> (12)..(12)
<223> Gamma-carboxyglutamic acid

<400> 191
Ala Asp Asp Gln Asn Pro Trp Arg Ala Tyr Leu Xaa Leu Leu Phe Pro 
1               5                   10                  15      


Thr Asp Thr Leu Leu Leu Asp Leu Leu Trp 
            20                  25      


<210> 192
<211> 26
<212> PRT
<213> Artificial Sequence

<220>
<223> Description of Artificial Sequence: Synthetic
      peptide


<220>
<221> MOD_RES
<222> (18)..(18)
<223> Gamma-carboxyglutamic acid

<400> 192
Ala Asp Asp Gln Asn Pro Trp Arg Ala Tyr Leu Asp Leu Leu Phe Pro 
1               5                   10                  15      


Thr Xaa Thr Leu Leu Leu Asp Leu Leu Trp 
            20                  25      


<210> 193
<211> 26
<212> PRT
<213> Artificial Sequence

<220>
<223> Description of Artificial Sequence: Synthetic
      peptide


<220>
<221> MOD_RES
<222> (23)..(23)
<223> Gamma-carboxyglutamic acid

<400> 193
Ala Asp Asp Gln Asn Pro Trp Arg Ala Tyr Leu Asp Leu Leu Phe Pro 
1               5                   10                  15      


Thr Asp Thr Leu Leu Leu Xaa Leu Leu Trp 
            20                  25      


<210> 194
<211> 26
<212> PRT
<213> Artificial Sequence

<220>
<223> Description of Artificial Sequence: Synthetic
      peptide


<220>
<221> MOD_RES
<222> (12)..(12)
<223> Gamma-carboxyglutamic acid

<220>
<221> MOD_RES
<222> (18)..(18)
<223> Gamma-carboxyglutamic acid

<400> 194
Ala Asp Asp Gln Asn Pro Trp Arg Ala Tyr Leu Xaa Leu Leu Phe Pro 
1               5                   10                  15      


Thr Xaa Thr Leu Leu Leu Asp Leu Leu Trp 
            20                  25      


<210> 195
<211> 26
<212> PRT
<213> Artificial Sequence

<220>
<223> Description of Artificial Sequence: Synthetic
      peptide


<220>
<221> MOD_RES
<222> (12)..(12)
<223> Gamma-carboxyglutamic acid

<220>
<221> MOD_RES
<222> (23)..(23)
<223> Gamma-carboxyglutamic acid

<400> 195
Ala Asp Asp Gln Asn Pro Trp Arg Ala Tyr Leu Xaa Leu Leu Phe Pro 
1               5                   10                  15      


Thr Asp Thr Leu Leu Leu Xaa Leu Leu Trp 
            20                  25      


<210> 196
<211> 26
<212> PRT
<213> Artificial Sequence

<220>
<223> Description of Artificial Sequence: Synthetic
      peptide


<220>
<221> MOD_RES
<222> (18)..(18)
<223> Gamma-carboxyglutamic acid

<220>
<221> MOD_RES
<222> (23)..(23)
<223> Gamma-carboxyglutamic acid

<400> 196
Ala Asp Asp Gln Asn Pro Trp Arg Ala Tyr Leu Asp Leu Leu Phe Pro 
1               5                   10                  15      


Thr Xaa Thr Leu Leu Leu Xaa Leu Leu Trp 
            20                  25      


<210> 197
<211> 26
<212> PRT
<213> Artificial Sequence

<220>
<223> Description of Artificial Sequence: Synthetic
      peptide


<220>
<221> MOD_RES
<222> (12)..(12)
<223> Gamma-carboxyglutamic acid

<220>
<221> MOD_RES
<222> (18)..(18)
<223> Gamma-carboxyglutamic acid

<220>
<221> MOD_RES
<222> (23)..(23)
<223> Gamma-carboxyglutamic acid

<400> 197
Ala Asp Asp Gln Asn Pro Trp Arg Ala Tyr Leu Xaa Leu Leu Phe Pro 
1               5                   10                  15      


Thr Xaa Thr Leu Leu Leu Xaa Leu Leu Trp 
            20                  25      


<210> 198
<211> 26
<212> PRT
<213> Artificial Sequence

<220>
<223> Description of Artificial Sequence: Synthetic
      peptide


<220>
<221> MOD_RES
<222> (12)..(12)
<223> Alpha-aminoadipic acid

<400> 198
Ala Asp Asp Gln Asn Pro Trp Arg Ala Tyr Leu Xaa Leu Leu Phe Pro 
1               5                   10                  15      


Thr Asp Thr Leu Leu Leu Asp Leu Leu Trp 
            20                  25      


<210> 199
<211> 26
<212> PRT
<213> Artificial Sequence

<220>
<223> Description of Artificial Sequence: Synthetic
      peptide


<220>
<221> MOD_RES
<222> (18)..(18)
<223> Alpha-aminoadipic acid

<400> 199
Ala Asp Asp Gln Asn Pro Trp Arg Ala Tyr Leu Asp Leu Leu Phe Pro 
1               5                   10                  15      


Thr Xaa Thr Leu Leu Leu Asp Leu Leu Trp 
            20                  25      


<210> 200
<211> 26
<212> PRT
<213> Artificial Sequence

<220>
<223> Description of Artificial Sequence: Synthetic
      peptide


<220>
<221> MOD_RES
<222> (23)..(23)
<223> Alpha-aminoadipic acid

<400> 200
Ala Asp Asp Gln Asn Pro Trp Arg Ala Tyr Leu Asp Leu Leu Phe Pro 
1               5                   10                  15      


Thr Asp Thr Leu Leu Leu Xaa Leu Leu Trp 
            20                  25      


<210> 201
<211> 26
<212> PRT
<213> Artificial Sequence

<220>
<223> Description of Artificial Sequence: Synthetic
      peptide


<220>
<221> MOD_RES
<222> (12)..(12)
<223> Alpha-aminoadipic acid

<220>
<221> MOD_RES
<222> (18)..(18)
<223> Alpha-aminoadipic acid

<400> 201
Ala Asp Asp Gln Asn Pro Trp Arg Ala Tyr Leu Xaa Leu Leu Phe Pro 
1               5                   10                  15      


Thr Xaa Thr Leu Leu Leu Asp Leu Leu Trp 
            20                  25      


<210> 202
<211> 26
<212> PRT
<213> Artificial Sequence

<220>
<223> Description of Artificial Sequence: Synthetic
      peptide


<220>
<221> MOD_RES
<222> (12)..(12)
<223> Alpha-aminoadipic acid

<220>
<221> MOD_RES
<222> (23)..(23)
<223> Alpha-aminoadipic acid

<400> 202
Ala Asp Asp Gln Asn Pro Trp Arg Ala Tyr Leu Xaa Leu Leu Phe Pro 
1               5                   10                  15      


Thr Asp Thr Leu Leu Leu Xaa Leu Leu Trp 
            20                  25      


<210> 203
<211> 26
<212> PRT
<213> Artificial Sequence

<220>
<223> Description of Artificial Sequence: Synthetic
      peptide


<220>
<221> MOD_RES
<222> (18)..(18)
<223> Alpha-aminoadipic acid

<220>
<221> MOD_RES
<222> (23)..(23)
<223> Alpha-aminoadipic acid

<400> 203
Ala Asp Asp Gln Asn Pro Trp Arg Ala Tyr Leu Asp Leu Leu Phe Pro 
1               5                   10                  15      


Thr Xaa Thr Leu Leu Leu Xaa Leu Leu Trp 
            20                  25      


<210> 204
<211> 26
<212> PRT
<213> Artificial Sequence

<220>
<223> Description of Artificial Sequence: Synthetic
      peptide


<220>
<221> MOD_RES
<222> (12)..(12)
<223> Alpha-aminoadipic acid

<220>
<221> MOD_RES
<222> (18)..(18)
<223> Alpha-aminoadipic acid

<220>
<221> MOD_RES
<222> (23)..(23)
<223> Alpha-aminoadipic acid

<400> 204
Ala Asp Asp Gln Asn Pro Trp Arg Ala Tyr Leu Xaa Leu Leu Phe Pro 
1               5                   10                  15      


Thr Xaa Thr Leu Leu Leu Xaa Leu Leu Trp 
            20                  25      


<210> 205
<211> 26
<212> PRT
<213> Artificial Sequence

<220>
<223> Description of Artificial Sequence: Synthetic
      peptide


<220>
<221> MOD_RES
<222> (12)..(12)
<223> Gamma-carboxyglutamic acid

<220>
<221> MOD_RES
<222> (18)..(18)
<223> Alpha-aminoadipic acid

<400> 205
Ala Asp Asp Gln Asn Pro Trp Arg Ala Tyr Leu Xaa Leu Leu Phe Pro 
1               5                   10                  15      


Thr Xaa Thr Leu Leu Leu Asp Leu Leu Trp 
            20                  25      


<210> 206
<211> 26
<212> PRT
<213> Artificial Sequence

<220>
<223> Description of Artificial Sequence: Synthetic
      peptide


<220>
<221> MOD_RES
<222> (12)..(12)
<223> Gamma-carboxyglutamic acid

<220>
<221> MOD_RES
<222> (23)..(23)
<223> Alpha-aminoadipic acid

<400> 206
Ala Asp Asp Gln Asn Pro Trp Arg Ala Tyr Leu Xaa Leu Leu Phe Pro 
1               5                   10                  15      


Thr Asp Thr Leu Leu Leu Xaa Leu Leu Trp 
            20                  25      


<210> 207
<211> 26
<212> PRT
<213> Artificial Sequence

<220>
<223> Description of Artificial Sequence: Synthetic
      peptide


<220>
<221> MOD_RES
<222> (12)..(12)
<223> Gamma-carboxyglutamic acid

<220>
<221> MOD_RES
<222> (18)..(18)
<223> Gamma-carboxyglutamic acid

<220>
<221> MOD_RES
<222> (23)..(23)
<223> Alpha-aminoadipic acid

<400> 207
Ala Asp Asp Gln Asn Pro Trp Arg Ala Tyr Leu Xaa Leu Leu Phe Pro 
1               5                   10                  15      


Thr Xaa Thr Leu Leu Leu Xaa Leu Leu Trp 
            20                  25      


<210> 208
<211> 26
<212> PRT
<213> Artificial Sequence

<220>
<223> Description of Artificial Sequence: Synthetic
      peptide


<220>
<221> MOD_RES
<222> (12)..(12)
<223> Alpha-aminoadipic acid

<220>
<221> MOD_RES
<222> (18)..(18)
<223> Gamma-carboxyglutamic acid

<400> 208
Ala Asp Asp Gln Asn Pro Trp Arg Ala Tyr Leu Xaa Leu Leu Phe Pro 
1               5                   10                  15      


Thr Xaa Thr Leu Leu Leu Asp Leu Leu Trp 
            20                  25      


<210> 209
<211> 26
<212> PRT
<213> Artificial Sequence

<220>
<223> Description of Artificial Sequence: Synthetic
      peptide


<220>
<221> MOD_RES
<222> (12)..(12)
<223> Alpha-aminoadipic acid

<220>
<221> MOD_RES
<222> (23)..(23)
<223> Gamma-carboxyglutamic acid

<400> 209
Ala Asp Asp Gln Asn Pro Trp Arg Ala Tyr Leu Xaa Leu Leu Phe Pro 
1               5                   10                  15      


Thr Asp Thr Leu Leu Leu Xaa Leu Leu Trp 
            20                  25      


<210> 210
<211> 26
<212> PRT
<213> Artificial Sequence

<220>
<223> Description of Artificial Sequence: Synthetic
      peptide


<220>
<221> MOD_RES
<222> (12)..(12)
<223> Gamma-carboxyglutamic acid

<220>
<221> MOD_RES
<222> (18)..(18)
<223> Alpha-aminoadipic acid

<220>
<221> MOD_RES
<222> (23)..(23)
<223> Gamma-carboxyglutamic acid

<400> 210
Ala Asp Asp Gln Asn Pro Trp Arg Ala Tyr Leu Xaa Leu Leu Phe Pro 
1               5                   10                  15      


Thr Xaa Thr Leu Leu Leu Xaa Leu Leu Trp 
            20                  25      


<210> 211
<211> 29
<212> PRT
<213> Artificial Sequence

<220>
<223> Description of Artificial Sequence: Synthetic
      peptide

<400> 211
Gly Glu Glu Gln Asn Pro Trp Leu Gly Ala Tyr Leu Asp Leu Leu Phe 
1               5                   10                  15      


Pro Leu Glu Leu Leu Gly Leu Leu Glu Leu Gly Leu Trp 
            20                  25                  


<210> 212
<211> 28
<212> PRT
<213> Artificial Sequence

<220>
<223> Description of Artificial Sequence: Synthetic
      peptide

<400> 212
Ala Asp Asp Asp Asp Asp Asp Pro Trp Gln Ala Tyr Leu Asp Leu Leu 
1               5                   10                  15      


Phe Pro Thr Asp Thr Leu Leu Leu Asp Leu Leu Trp 
            20                  25              


<210> 213
<211> 26
<212> PRT
<213> Artificial Sequence

<220>
<223> Description of Artificial Sequence: Synthetic
      peptide

<400> 213
Ala Glu Glu Gln Asn Pro Trp Arg Ala Tyr Leu Glu Leu Leu Phe Pro 
1               5                   10                  15      


Thr Glu Thr Leu Leu Leu Glu Leu Leu Trp 
            20                  25      


<210> 214
<211> 24
<212> PRT
<213> Artificial Sequence

<220>
<223> Description of Artificial Sequence: Synthetic
      peptide

<400> 214
Ala Asp Asp Gln Asn Pro Trp Ala Arg Tyr Leu Asp Trp Leu Phe Pro 
1               5                   10                  15      


Thr Asp Thr Leu Leu Leu Asp Leu 
            20                  


<210> 215
<211> 23
<212> PRT
<213> Artificial Sequence

<220>
<223> Description of Artificial Sequence: Synthetic
      peptide

<400> 215
Asp Asn Asn Asn Pro Trp Arg Ala Tyr Leu Asp Leu Leu Phe Pro Thr 
1               5                   10                  15      


Asp Thr Leu Leu Leu Asp Trp 
            20              


<210> 216
<211> 24
<212> PRT
<213> Artificial Sequence

<220>
<223> Description of Artificial Sequence: Synthetic
      peptide

<400> 216
Ala Glu Glu Gln Asn Pro Trp Ala Arg Tyr Leu Glu Trp Leu Phe Pro 
1               5                   10                  15      


Thr Glu Thr Leu Leu Leu Glu Leu 
            20                  


<210> 217
<211> 25
<212> PRT
<213> Artificial Sequence

<220>
<223> Description of Artificial Sequence: Synthetic
      peptide

<400> 217
Asp Asp Asp Asp Asp Asp Pro Trp Gln Ala Tyr Leu Asp Leu Phe Pro 
1               5                   10                  15      


Thr Asp Thr Leu Ala Leu Asp Leu Trp 
            20                  25  


<210> 218
<211> 23
<212> PRT
<213> Artificial Sequence

<220>
<223> Description of Artificial Sequence: Synthetic
      peptide

<400> 218
Glu Glu Gln Gln Pro Trp Ala Gln Tyr Leu Glu Leu Leu Phe Pro Thr 
1               5                   10                  15      


Glu Thr Leu Leu Leu Glu Trp 
            20              


<210> 219
<211> 23
<212> PRT
<213> Artificial Sequence

<220>
<223> Description of Artificial Sequence: Synthetic
      peptide

<400> 219
Glu Glu Gln Gln Pro Trp Arg Ala Tyr Leu Glu Leu Leu Phe Pro Thr 
1               5                   10                  15      


Glu Thr Leu Leu Leu Glu Trp 
            20              


<210> 220
<211> 23
<212> PRT
<213> Artificial Sequence

<220>
<223> Description of Artificial Sequence: Synthetic
      peptide

<400> 220
Ala Glu Asp Gln Asn Pro Trp Ala Arg Tyr Ala Asp Trp Leu Phe Pro 
1               5                   10                  15      


Thr Thr Leu Leu Leu Leu Asp 
            20              


<210> 221
<211> 23
<212> PRT
<213> Artificial Sequence

<220>
<223> Description of Artificial Sequence: Synthetic
      peptide

<400> 221
Ala Glu Glu Gln Asn Pro Trp Ala Arg Tyr Ala Glu Trp Leu Phe Pro 
1               5                   10                  15      


Thr Thr Leu Leu Leu Leu Glu 
            20              


<210> 222
<211> 21
<212> PRT
<213> Artificial Sequence

<220>
<223> Description of Artificial Sequence: Synthetic
      peptide

<400> 222
Ala Glu Asp Gln Asn Pro Trp Ala Arg Tyr Ala Asp Leu Leu Phe Pro 
1               5                   10                  15      


Thr Thr Leu Ala Trp 
            20      


<210> 223
<211> 21
<212> PRT
<213> Artificial Sequence

<220>
<223> Description of Artificial Sequence: Synthetic
      peptide

<400> 223
Ala Glu Glu Gln Asn Pro Trp Ala Arg Tyr Ala Glu Leu Leu Phe Pro 
1               5                   10                  15      


Thr Thr Leu Ala Trp 
            20      


<210> 224
<211> 36
<212> PRT
<213> Artificial Sequence

<220>
<223> Description of Artificial Sequence: Synthetic
      polypeptide

<400> 224
Asp Asp Asp Asp Asp Asn Pro Asn Tyr Trp Ala Arg Tyr Ala Asn Trp 
1               5                   10                  15      


Leu Phe Thr Thr Pro Leu Leu Leu Leu Asn Gly Ala Leu Leu Val Glu 
            20                  25                  30          


Ala Glu Glu Thr 
        35      


<210> 225
<211> 36
<212> PRT
<213> Artificial Sequence

<220>
<223> Description of Artificial Sequence: Synthetic
      polypeptide

<400> 225
Asp Asp Asp Asp Asp Asn Pro Asn Tyr Trp Ala Arg Tyr Ala Pro Trp 
1               5                   10                  15      


Leu Phe Thr Thr Pro Leu Leu Leu Leu Pro Gly Ala Leu Leu Val Glu 
            20                  25                  30          


Ala Glu Glu Thr 
        35      


<210> 226
<211> 34
<212> PRT
<213> Artificial Sequence

<220>
<223> Description of Artificial Sequence: Synthetic
      polypeptide

<400> 226
Ala Glu Gln Asn Pro Ile Tyr Phe Ala Arg Tyr Ala Asp Phe Leu Phe 
1               5                   10                  15      


Thr Thr Pro Leu Leu Leu Leu Asp Leu Ala Leu Leu Trp Asp Ala Asp 
            20                  25                  30          


Glu Thr 
        


<210> 227
<211> 34
<212> PRT
<213> Artificial Sequence

<220>
<223> Description of Artificial Sequence: Synthetic
      polypeptide

<400> 227
Ala Glu Gln Asn Pro Ile Tyr Trp Ala Arg Tyr Ala Asp Phe Leu Phe 
1               5                   10                  15      


Thr Thr Pro Leu Leu Leu Leu Asp Leu Ala Leu Leu Val Asp Ala Asp 
            20                  25                  30          


Glu Thr 
        


<210> 228
<211> 20
<212> PRT
<213> Artificial Sequence

<220>
<223> Description of Artificial Sequence: Synthetic
      peptide

<400> 228
Ala Glu Gln Asn Pro Ile Tyr Trp Ala Arg Tyr Ala Asp Trp Leu Phe 
1               5                   10                  15      


Thr Thr Pro Leu 
            20  


<210> 229
<211> 22
<212> PRT
<213> Artificial Sequence

<220>
<223> Description of Artificial Sequence: Synthetic
      peptide

<400> 229
Ala Glu Gln Asn Pro Ile Tyr Phe Ala Arg Tyr Ala Asp Leu Leu Phe 
1               5                   10                  15      


Pro Thr Thr Leu Ala Trp 
            20          


<210> 230
<211> 22
<212> PRT
<213> Artificial Sequence

<220>
<223> Description of Artificial Sequence: Synthetic
      peptide

<400> 230
Ala Glu Gln Asn Pro Ile Tyr Trp Ala Arg Tyr Ala Asp Leu Leu Phe 
1               5                   10                  15      


Pro Thr Thr Leu Ala Phe 
            20          


<210> 231
<211> 22
<212> PRT
<213> Artificial Sequence

<220>
<223> Description of Artificial Sequence: Synthetic
      peptide

<400> 231
Ala Glu Gln Asn Pro Ile Tyr Trp Ala Arg Tyr Ala Asp Leu Leu Phe 
1               5                   10                  15      


Pro Thr Thr Leu Ala Trp 
            20          


<210> 232
<211> 20
<212> PRT
<213> Artificial Sequence

<220>
<223> Description of Artificial Sequence: Synthetic
      peptide

<400> 232
Ala Glu Gln Asn Pro Ile Tyr Phe Ala Arg Tyr Ala Asp Trp Leu Phe 
1               5                   10                  15      


Thr Thr Pro Leu 
            20  


<210> 233
<211> 20
<212> PRT
<213> Artificial Sequence

<220>
<223> Description of Artificial Sequence: Synthetic
      peptide

<400> 233
Glu Asp Gln Asn Pro Trp Ala Arg Tyr Ala Asp Leu Leu Phe Pro Thr 
1               5                   10                  15      


Thr Leu Ala Trp 
            20  


<210> 234
<211> 34
<212> PRT
<213> Artificial Sequence

<220>
<223> Description of Artificial Sequence: Synthetic
      polypeptide

<400> 234
Gly Leu Ala Gly Leu Ala Gly Leu Leu Gly Leu Glu Gly Leu Leu Gly 
1               5                   10                  15      


Leu Pro Leu Gly Leu Leu Glu Gly Leu Trp Leu Gly Leu Glu Leu Glu 
            20                  25                  30          


Gly Asn 
        


<210> 235
<211> 32
<212> PRT
<213> Artificial Sequence

<220>
<223> Description of Artificial Sequence: Synthetic
      polypeptide

<400> 235
Glu Gln Asn Pro Ile Tyr Ile Leu Asp Leu Val Phe Gly Leu Leu Phe 
1               5                   10                  15      


Ala Val Thr Ser Val Asp Phe Leu Val Gln Trp Asp Asp Ala Gly Asp 
            20                  25                  30          


<210> 236
<211> 24
<212> PRT
<213> Artificial Sequence

<220>
<223> Description of Artificial Sequence: Synthetic
      peptide

<400> 236
Asn Leu Glu Gly Phe Phe Ala Thr Leu Gly Gly Glu Ile Ala Leu Trp 
1               5                   10                  15      


Ser Leu Val Val Leu Ala Ile Glu 
            20                  


<210> 237
<211> 24
<212> PRT
<213> Artificial Sequence

<220>
<223> Description of Artificial Sequence: Synthetic
      peptide

<400> 237
Asn Asn Glu Gly Phe Phe Ala Thr Leu Gly Gly Glu Ile Ala Leu Trp 
1               5                   10                  15      


Ser Asp Val Val Leu Ala Ile Glu 
            20                  


<210> 238
<211> 25
<212> PRT
<213> Artificial Sequence

<220>
<223> Description of Artificial Sequence: Synthetic
      peptide

<400> 238
Asp Asn Asn Glu Gly Phe Phe Ala Thr Leu Gly Gly Glu Ile Pro Leu 
1               5                   10                  15      


Trp Ser Asp Val Val Leu Ala Ile Glu 
            20                  25  


<210> 239
<211> 28
<212> PRT
<213> Artificial Sequence

<220>
<223> Description of Artificial Sequence: Synthetic
      peptide


<220>
<221> MOD_RES
<222> (1)..(28)
<223> D-amino acid

<400> 239
Ala Lys Asp Asp Gln Asn Pro Trp Arg Ala Tyr Leu Asp Leu Leu Phe 
1               5                   10                  15      


Pro Thr Asp Thr Leu Leu Leu Asp Leu Leu Trp Ala 
            20                  25              


<210> 240
<211> 28
<212> PRT
<213> Artificial Sequence

<220>
<223> Description of Artificial Sequence: Synthetic
      peptide


<220>
<221> MOD_RES
<222> (1)..(28)
<223> D-amino acid

<220>
<221> MOD_RES
<222> (2)..(2)
<223> a (3,14,25-trihydroxy-2,10,13,21,24-pentaoxo-3,9,14,20,25
      -pentaazatriacontan-30-yl)amino group covalently associated by a
      bond or through a covalent linker with a heteroatom of a side
      chain of an amino acid residue of the peptide sequence, a

<220>
<221> MOD_RES
<222> (2)..(2)
<223> CONT. FROM ABOVE: (3,14,25,36-tetrahydroxy-2,10,13,21,24,32,35
      -heptaoxo-3,9,14,20,25,31,36-heptaazahentetracontan-41-yl)amino
      group covalently associated by a bond or through a covalent
      linker with a heteroatom of a side chain of an amino acid

<220>
<221> MOD_RES
<222> (2)..(2)
<223> CONT. FROM ABOVE: residue of the peptide sequence, or a 16-(1
      -hydroxy-6-oxo-1,6-dihydropyridin-2-yl)-2,6,11-tris(1-hydroxy
      -6-oxo-1,6-dihydropyridine-2-carbonyl)-16-oxo-2,6,11,15
      -tetraazahexadecyl group covalently associated by a bond or

<220>
<221> MOD_RES
<222> (2)..(2)
<223> CONT. FROM ABOVE: through a covalent linker with a heteroatom
      of a side chain of an amino acid residue of the peptide sequence

<220> 
<223> See specification as filed for detailed description of
      substitutions and preferred embodiments

<400> 240
Ala Lys Asp Asp Gln Asn Pro Trp Arg Ala Tyr Leu Asp Leu Leu Phe 
1               5                   10                  15      


Pro Thr Asp Thr Leu Leu Leu Asp Leu Leu Trp Ala 
            20                  25              


<210> 241
<211> 28
<212> PRT
<213> Artificial Sequence

<220>
<223> Description of Artificial Sequence: Synthetic
      peptide


<220>
<221> MOD_RES
<222> (1)..(28)
<223> D-amino acid

<220>
<221> MOD_RES
<222> (2)..(2)
<223> a (3,14,25-trihydroxy-2,10,13,21,24-pentaoxo-3,9,14,20,25
      -pentaazatriacontan-30-yl)amino group chelating a radionuclide
      where the group is covalently associated by a bond or through a
      covalent linker with a heteroatom of a side chain of an amino

<220>
<221> MOD_RES
<222> (2)..(2)
<223> CONT. FROM ABOVE: acid residue of the peptide sequence, a
      (3,14,25,36-tetrahydroxy-2,10,13,21,24,32,35-heptaoxo
      -3,9,14,20,25,31,36-heptaazahentetracontan-41-yl)amino group
      chelating a radionuclide where the group is covalently 

<220>
<221> MOD_RES
<222> (2)..(2)
<223> CONT. FROM ABOVE: associated by a bond or through a covalent
      linker with a heteroatom of a side chain of an amino acid
      residue of the peptide sequence, or a 16-(1-hydroxy-6-oxo-1,6
      -dihydropyridin-2-yl)-2,6,11-tris(1-hydroxy-6-oxo-1,6

<220>
<221> MOD_RES
<222> (2)..(2)
<223> CONT. FROM ABOVE: -dihydropyridine-2-carbonyl)-16-oxo-2,6,11,15
      -tetraazahexadecyl chelating a radionuclide where the group is
      group covalently associated by a bond or through a covalent
      linker with a heteroatom of a side chain of an amino acid

<220>
<221> MOD_RES
<222> (2)..(2)
<223> CONT. FROM ABOVE: residue of the peptide sequence

<220> 
<223> See specification as filed for detailed description of
      substitutions and preferred embodiments

<400> 241
Ala Lys Asp Asp Gln Asn Pro Trp Arg Ala Tyr Leu Asp Leu Leu Phe 
1               5                   10                  15      


Pro Thr Asp Thr Leu Leu Leu Asp Leu Leu Trp Ala 
            20                  25              


<210> 242
<211> 28
<212> PRT
<213> Artificial Sequence

<220>
<223> Description of Artificial Sequence: Synthetic
      peptide


<220>
<221> MOD_RES
<222> (1)..(28)
<223> D-amino acid

<220>
<221> MOD_RES
<222> (2)..(2)
<223> 3,4-dioxo-2-((3,14,25-trihydroxy-2,10,13,21,24-pentaoxo
      -3,9,14,20,25-pentaazatriacontan-30-yl)amino)cyclobut-1-en-1-yl
      covalently attached to the epsilon-nitrogen atom of the 
      indicated D-lysine, (4-(1-(1-hydroxy-6-oxo-1,6-dihydropyridin-2

<220>
<221> MOD_RES
<222> (2)..(2)
<223> CONT. FROM ABOVE: -yl)-6,11,15-tris(1-hydroxy-6-oxo-1,6
      -dihydropyridine-2-carbonyl)-1-oxo-2,6,11,15-tetraazaheptadecan
      -17-yl)phenyl)carbamothioyl covalently attached to the epsilon
      -nitrogen atom of the indicated D-lysine, (4-(3-(3,14,25,36

<220>
<221> MOD_RES
<222> (2)..(2)
<223> CONT. FROM ABOVE: -tetrahydroxy -2,10,13,21,24,32,35-heptaoxo
      -3,9,14,20,25,31,36-heptaazahentetracontan-41-yl)thioureido)
      phenyl)carbamothioyl covalently attached to the epsilon-nitrogen
      atom of the indicated D-lysine, or (4-(3-(3,14,25-trihydroxy

<220>
<221> MOD_RES
<222> (2)..(2)
<223> CONT. FROM ABOVE: -2,10,13,21,24-pentaoxo-3,9,14,20,25
      -pentaazatriacontan-30-yl)thioureido)phenyl)carbamothioyl 
      covalently attached to the epsilon-nitrogen atom of the
      indicated D-lysine

<220> 
<223> See specification as filed for detailed description of
      substitutions and preferred embodiments

<400> 242
Ala Lys Asp Asp Gln Asn Pro Trp Arg Ala Tyr Leu Asp Leu Leu Phe 
1               5                   10                  15      


Pro Thr Asp Thr Leu Leu Leu Asp Leu Leu Trp Ala 
            20                  25              


<210> 243
<211> 37
<212> PRT
<213> Artificial Sequence

<220>
<223> Description of Artificial Sequence: Synthetic
      polypeptide


<220>
<221> MOD_RES
<222> (1)..(34)
<223> D-amino acid

<220>
<221> MOD_RES
<222> (36)..(36)
<223> D-amino acid

<400> 243
Ala Lys Glu Gln Asn Pro Ile Tyr Trp Ala Arg Tyr Ala Asp Trp Leu 
1               5                   10                  15      


Phe Thr Thr Pro Leu Leu Leu Leu Asp Leu Ala Leu Leu Val Asp Ala 
            20                  25                  30          


Asp Glu Gly Thr Gly 
        35          


<210> 244
<211> 37
<212> PRT
<213> Artificial Sequence

<220>
<223> Description of Artificial Sequence: Synthetic
      polypeptide


<220>
<221> MOD_RES
<222> (1)..(34)
<223> D-amino acid

<220>
<221> MOD_RES
<222> (2)..(2)
<223> (4-(3-(3,14,25-trihydroxy-2,10,13,21,24-pentaoxo-3,9,14,20,25
      -pentaazatriacontan-30-yl)thioureido)phenyl)carbamothioyl
      covalently attached to the epsilon-nitrogen atom of the
      indicated D-lysine

<220>
<221> MOD_RES
<222> (36)..(36)
<223> D-amino acid

<220> 
<223> See specification as filed for detailed description of
      substitutions and preferred embodiments

<400> 244
Ala Lys Glu Gln Asn Pro Ile Tyr Trp Ala Arg Tyr Ala Asp Trp Leu 
1               5                   10                  15      


Phe Thr Thr Pro Leu Leu Leu Leu Asp Leu Ala Leu Leu Val Asp Ala 
            20                  25                  30          


Asp Glu Gly Thr Gly 
        35          


